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INTRODUCTION  
  
 
 Leg ulcers are chronic conditions with prolonged courses and refractory 
healing.  Multifaceted treatment is needed for the management of leg ulcers 
like proper wound care practices, compression therapy and surgical procedures. 
Chronic leg ulcers are common disease which affects 0.12% to 1.1% of world 
population and non healing ulcer with dermatitis is a common problem
. 1 
 
 Since the time duration is longer for the management of leg ulcers, the 
patients are exposed to many topical medicaments and medicaments 
incorporated dressing. Application of these medicaments to the barrier 
disrupted skin lead to contact sensitisation to these substances. Contact 
sensitisation will lead to allergic contact dermatitis of the skin surrounding the 
leg ulcers.
2 
 
Allergic contact dermatitis of the surrounding skin, in turn, can impede 
the healing of ulcers and restrict the choice of treatment. In already sensitized 
leg ulcer patients, allergic contact dermatitis can develop at the sites other than 
legs due to direct allergens exposure, dissemination from ulcer site, or systemic 
spread.
3
   In India, patients tend to use topical medicaments injudiciously and 
frequently because topical medicaments are available over the counter.   So 
chances of contact allergy are more in our country. 
 
3 
 
 
The high incidence of contact sensitization in the leg ulcer patient is due to  
1.  The intrinsic allergenic properties of different ointments, creams and 
 wound care products used to heal the ulcer  
2.  The excessive duration of use of these medicaments 
3. The disrupted skin barrier to which these products are applied.
4
   These 
conditions may lead to contact dermatitis of the leg, ultimately 
impairing healing and prolonged morbidity associated with leg 
ulcerations. Recurrence of leg ulcers can be due to persistent or 
recurrent dermatitis. 
 
The spectrum of the most frequent contact allergens among leg ulcer 
patients mainly depends on the local practice of wound treatment.   One study 
reported a direct relationship between the duration of leg ulcers and the number 
of multiple positive allergen sensitivities.   From this study findings suggest 
that an ulcer of long duration has greater opportunity for contact with different 
allergens and leads to increased sensitivity to this allergens.
5 
 
Contact sensitisation rates are very high, ranging from 60%-80% in 
various studies.
2
   One study reported at least one positive patch test reaction to 
the allergens of the European baseline series were documented in 80% of the 
patients.
6
   In a North American study showed that 63% of the patients had one 
or more allergen sensitizations.
7
   In another study among the 423 patients, 
73% had   positive patch test reaction.
8
   
4 
 
 
 Although several studies have conducted with contact allergy in leg 
ulcer patients in other countries, studies using leg ulcer series has not been 
conducted in India. Hence we have conducted study in leg ulcer patients to 
detect contact sensitisation by using leg ulcer series patch test.  Because of 
higher proportion of contact allergies in chronic leg ulcer patients suggest that 
all leg ulcers with or without associated dermatitis should be patch tested with 
leg ulcer series. 
5 
 
 
 
 
 
 
 
 
 
 
  AIMS AND OBJECTIVES 
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AIMS AND OBJECTIVES 
 
1 To determine the frequency of contact sensitization in patients with leg 
 ulcers  using a leg ulcer patch test series. 
 
2. Revealing the associations between chronic leg ulcers and contact 
 sensitization. 
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REVIEW OF LITERATURE 
Leg Ulcers  
 Leg ulcers are a common condition affecting 0.12% - 1.1% of the 
population worldwide.
1
   It refers to full thickness skin loss on the leg or foot. 
Among the various causes of leg ulcers, 70% of them are due to venous 
disorder, 20% of them are due to mixed arterial and venous disease and 10% of 
leg ulcers are due to other causes Ex.neuropathy, infections, malignancy, and 
haematological disease. 
 
        According to few Indian studies, prevalence of chronic leg ulcer is 
4.5 per 1000 population and the incidence of acute ulcer is 10.5 per 1000 
population.
9
 
 
Wound healing society estimated that 15% of older adults in the United 
States suffer from chronic leg ulcer. Almost 2 to 3 million new cases are 
diagnosed per year in America. The prevalence of vascular ulcer in the United 
States is 500,000 to 600,000.  Annual incidence of leg ulcer in UK is 3.5 per 
1000 individuals and annual incidence in Switzerland is 0.2 per 1000 
individuals.
10
  
   
 
One study in Ireland reported that prevalence was 0.12% but prevalence 
was 1.03% in the patients aged 70 years and over.   Women were twice 
affected than males. Venous disease responsible for 81% of ulcers and the 
arterial disease accounted for 16.3% of ulcers.  Leg ulcers are an important 
cause of morbidity in ageing population.
11 
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Leg ulcers can be classified according to duration of ulcer 
1. Acute leg ulcer :     Ulcer persists less than 6 weeks duration 
2. Chronic leg ulcer:  Ulcer persists more than 6 weeks duration.
12 
Table 1: Various causes of leg ulcers .
13 
1. Vascular disease 
i.  Venous disease 
Ex .venous stasis ulcer 
ii.  Arterial disease 
Ex.atherosclerosis, hypertensive 
ulcers, 
thrombhoangitis obliterans 
iii. Mixed (both arterial and 
venous) 
iv. Lymphedema 
Ex.congenital lymphedema,post 
surgical and post infectious 
lymphedema 
v. Vasculitis 
Ex.polyarteritis nodosa, systemic 
lupus erythematosus. Rhematoid 
vasculitis 
2.Hematological abnormalities 
i.Disorder of red blood cells 
Ex.Thalassemia, sickle cell anemia, 
polycythemia vera 
 
ii.Disorder of white blood cells 
Ex .leukemia 
 
iii.Dysproteinemia 
Ex.cryoglobulinemia,macroglobulinemia 
 
iv. Hypercoagulable states 
Ex .Protein C and protein S  
deficiency,antiphospholipid antibody 
syndrome paroxysmal nocturnal 
hemoglobinuria 
3. Neuropathic ulcers 
i. Diabetes mellitus 
ii.Hansen‟s disease 
iii. Tabes dorsalis  
4. Infections 
i.Bacterial infection ex.staphylococcus 
aureus,streptococcus 
ii.Spirochetal ex. Syphilis 
iii.Opportunistic infection in 
immunocompromised 
iv.Fungal infection ex.deep fungal 
infection, mycetoma  
5.Neoplasms 
i.Basal cell carcinoma 
ii. Squamous cell carcinoma 
 
 
 
6. Drugs 
i.Ergotism 
ii.Halogens 
iii.Hydroxyl urea 
iv.Anticoagulant necrosis 
7. Metabolic disorder 
i.Diabetes mellitus 
ii.Gout 
iii.Porphyria cutanea tarda 
iv.Prolidase deficiency 
 
8 .Miscellaneous 
i.Pyoderma gangrenosum. 
ii.Epidermolysis bullosa 
iii.Ulcerative lichen planus 
iv.Idiopathic 
v.Klinefelter‟s syndrome 
10 
 
Venous Ulcers 
 Venous ulcers are also called as gravitational ulcer, stasis ulcer, varicose 
ulcer and hypostatic ulcer. Venous ulcer is a complication of varicose veins and 
deep vein thrombosis.
14 
 
Anatomy of lower limb veins:  
Lower limb veins can be divided into 
1. Superficial veins  
2. Deep veins 
3. Perforator veins 
 
 
 
Fig: Veins of the lower limb 
1. Superficial veins  
Superficial veins are thick-walled and lie in the superficial fascia on 
the surface of the deep fascia. Superficial veins contain multiple valves 
which is important to facilitate blood flow towards heart. In the lower 
limbs venous blood flows from the skin to superficial vein which drain 
into deep vein. 
i. Long or great saphenous vein and its tributaries 
ii. Short/small saphenous vein and its tributaries 
11 
 
2. Deep Veins 
 i.  Femoral Veins  
ii.  Anterior and posterior tibial veins 
iii.  Popliteal Veins 
iv. Peroneal veins 
v. Medial and lateral plantar veins 
vi. Dorsalis pedis 
 
3. Pumping Veins: These veins are venous sinuses which pump blood towards 
heart. They are also known as the peripheral heart.
15
 
 
Perforator Veins 
Perforator veins connect superficial veins to deep veins at various levels 
 
Fig 2: Perforator veins of the lower limb  
Types :  
1. Hunter‟s perforator in the thigh                              
2. Mid thigh perforators (Dodd) 
3. Gastronemius Perforators (of boyd) 
4. Lower leg perforators (of Cockett) 
5. Ankle perforators (May or kuster).
15 
12 
 
Physiology of venous blood flow 
 Veins are thin-walled vessels and collapsible. Lower limb veins contain 
multiple valves and the number of valves decreases proximally. 
 
Factors responsible for venous return  
1.  Pumping action of vein is increased by aterial pressure across the capillary  
2. Calf musculovenous pump: Pressure in the calf muscles increases to 200-
300mm Hg during contraction phase of walking.  This pressure pumps the 
blood towards the heart.  During relaxation phase, pressure in the calf muscle is 
decreased.  It allows blood to flow from superficial veins to deep veins through 
perforators.  While walking, pressure in the superficial veins at the level of 
ankle is 20 mmHg. 
3. While walking, foot pump mechanism also propels blood from plantar veins 
into the leg veins. 
4. Gravity.
16 
 
Varicose veins 
 They are dilated, tortuous elongated veins.  The prevalence of varicose 
veins in the western population is 10-50%.  
 
Primary varicose veins 
 They have no obvious underlying cause. They are associated with 
valvular incompetence. 
 
13 
 
Secondary varicose veins 
 They are the result of raised endoluminal venous pressure. Post –
thrombotic damage is the most common cause for secondary varicose veins.
17 
 
Risk factors for varicose veins
18 
 
1. Hereditary 
Several studies have reported a genetic predisposition to the 
development of varicosities. This may be due to abnormalities in the FOXC2 
gene  
2. Age 
3. Sex:  High prevalence is seen in women 
4. Pregnancy 
5. Other factors: obesity, occupations which involve prolonged standing. 
 
Pathogenesis of venous ulcer  
Various theories have been postulated to explain the pathomechanism of 
venous ulceration. 
 
1. Capillary stasis 
Homans stated that stasis of venous blood gave rise to the development 
of anoxia which could lead to venous ulcers.
19 
  
 
 
14 
 
2. Fibrin cuff-theory 
This theory was postulated by Browse and Burnand. Chronic venous in 
sufficiency is associated with high venous pressure which leads to leakage of 
large molecules such as fibrinogen. Fibrinogen polymerize to insoluble fibrin 
in the interstitial space to form a pericapillary fibrin „cuff‟. This cuff can 
function as an oxygen diffusion barrier.
20
    
 
 
3. White Cell Trapping 
 Coleridge Smith et al. formulated white cell trapping theory. According 
to this theory leukocytes become trapped in the capillaries, obstructing flow 
which leads to ischemic ulceration. Adhesion molecules, like intercellular 
adhesion molecule-1 and vascular cell adhesion molecule -1, become over 
expressed in CVI leading too continuous migration of leucocytes to the 
dermis.
21
 
  
 
4. Trapping growth factors 
 Falanga and Eaglestein postulated that in CVI patients, the pericapillary 
fibrin cuffs prevent the transfer of growth factors. This may leads to delayed 
wound healing.
22
  
 
 
5. Multicausal model: The Maastricht model  
 
 
15 
 
Risk factors for venous ulceration
23 
Direct risk factors 
1. Varicosities 
2. Chronic venous insufficiency 
3. Deep vein thrombosis (DVT) 
4. Poor function of calf muscle 
5. Arterio venous malformation 
6. Obesity 
7. History of leg bone fracture 
 
Indirect factors 
1.  All risk factors which lead to deep vein thrombosis Ex.protein C and 
 protein S deficiency. 
2. Family history of varicosities.  
 
Venous Leg Ulcer Characteristics
23 
  Venous ulcer is located in the gaiter area of the leg, around the medial 
malleoli.  Ulceration can be discrete or circumferential. The ulcer bed is usually 
covered with a fibrinous layer mixed with granulation tissue. Ulcer edge is 
irregular and sloping. Pitting pedal edema is seen which is worse towards the 
end of the day.In chronic venous insufficiency, lipodermatosclerosis can occur. 
Severe lipodermatosclerosis leads to atrophic blanche and inverted champagne 
bottle appearance of leg.  Extravasation of RBC into the skin leads to 
pigmentation around ulcer site. 
16 
 
Pathogenesis of venous ulcer
24 
 
 
 
 
 
 
                               
 
  
 
                                     
 
 
  
                                   
  
                                 
 
 
 
 
Varicose veins or deep vein thrombosis which are recanalized, causes 
chronic venous hypertension around ankle 
Causes haemosiderin deposition in the subcutaneous plane from lysed 
RBC‟s 
Eczema 
Chronic Dermatitis 
Lipodermatosclerosis 
Fibrosis 
Anoxia  
Ulceration 
17 
 
 
Table - 2 
THE DIFFERENCE BETWEEN VENOUS AND ARTERIAL ULCER
25 
  
Venous ulcer 
 
 
Arterial ulcer 
History  Previous history of DVT 
Varicose veins 
Reduced mobility 
Obesity 
Pregnancy 
 
 
Diabetes 
Hypertension 
Smoking 
Previous history of 
peripheral vascular 
disease 
Complaints  Throbbing,aching,swelling 
of limbs and heavy feeling 
in legs 
 Improves with elevation of 
limb  
 
Intermittent 
claudication 
Rest pain in later 
stages 
Position of ulcer Gaiter area of the leg 
Common site is medial 
malleolar region 
 
 
Lateral malleolus and 
tibial area, toes and 
feet (over pressure 
points) 
Ulcer characteristics Single or multiple ulcers 
with irregular borders and 
sloping edge, shallow 
ulcers, moderate to heavy 
exudates 
 
 
Punched out, 
occasionally deep, 
presence of necrotic 
tissue, low exudates 
Condition of lower 
limb 
Limb edema, haemosiderin 
staining, varicose veins, 
lipodermatosclerosis, 
inverted champagne bottle 
appearance, peripheral 
pulsation present 
 
 
Thin shiny ,dry skin 
with loss of hair, cold 
limbs, pallor on leg 
elevation, absence or 
weak peripheral pulses 
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Arterial ulcers 
Arterial or arteriolar occlusion due to any reason may result in ischemia 
of the skin which may lead to ulceration. Peripheral vascular disease, diabetes 
and vasculitis might lead to ischemic limb resulting in ulceration. 
 
Three mechanisms are involved in the pathogenesis of arterial ulcer 
1. Extramural „strangulation‟ .Ex. scar tissue and radio dermatitis 
2. Mural thickening or accretion .Ex.atherosclerosis 
3. Intramural restriction of blood flow .Ex. disorders of micro vascular 
occlusion
27 
 
Trophic ulcer 
The Greek word trophe means “Nutrition”. 
Trophic ulcer is an “Ulcer due to impaired nutrition of the part”. 
 
Classification  
1. Neurogenic Ulcer:         Ex.hansens disease, diabetic neuropathy, 
                                        Syringomyelia, pressure ulcers, alcoholic  
                                        neuropathy. 
2. Vascular   
i.Arterial:                      Ex. peripheral vascular disease, atherosclerosis, 
                                            diabetes. 
ii.Venous:                     Ex.venous stasis ulcers. 
 3.Systemic Causes  
Malnutrition:               Ex.vitamin B12 deficiency 
19 
 
Neurogenic Ulcers: 
In neuropathy there is loss of pain sensation.  Due to repetitive trauma, 
shearing and frictional forces leads to ulceration. 
Etiology and Pathogenesis 
Dr. Paul Wilson Brand worked with south Indian leprosy patients in mid 
20
th
 century. He explained about the pathogenesis and various complications of 
leprosy. He said “Pain is God‟s greatest gift to mankind”.28 
Three reasons for plantar ulceration 
1.  Injuries from without 
 Because of loss of sensation, the sole is injured from outside and it is 
ignored which become infected and leads to a sore. 
2. Infection through a fissure in the skin 
The dry, anesthetic skin develops fissures or cracks in corns and 
callosities and become infected, and a sore develops. 
3. Breakdown of tissue from with –in (due to walking) 
While walking the forepart of the foot is subjected to stress and strain 
which are countered by foot muscle. Due to paralysis of foot muscle, certain 
areas are overloaded, causes the tissues to break down, leading to secondary 
ulceration. 
Stages of trophic ulcer  
1. Threatened ulceration. 2. Concealed ulceration (stage of „necrosis blister‟). 
 3. Open ulceration
29
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Diabetic foot ulcer   
The pathogenesis of diabetic ulcer is multifactorial. It is due to nerve 
damage and neuropathy, ischemic damage and peripheral vascular disease. The 
incidence of neuroischaemic leg ulcers is 52.3%, neuropathic leg ulcers 36% 
and ischemic leg ulcers 11.7%.
30 
 
Table 3 :Wagner classification for diabetic foot ulcers
30 
Grade Description of ulcer 
0 Preulcerative lesion/healed lesion 
I superficial ulcers  
II Ulcers deeper to subcutaneous tissue exposing soft tissues or bone 
III Abscess formation underneath/osteomyelitis 
IV Gangrene of part of the tissues/limb 
V Gangrene of the entire one area 
 
 
Haematological disorders 
Non–healing ulcers are a feature of sickle cell disease, hereditary 
spherocytosis, thalasaemia and other haemolytic anaemia‟s due to blockage of 
microcirculation. Thrombotic and occlusive disease can lead to rapid skin 
necrosis and gangrene. Ex. Protein C and protein S deficiency.
31 
 
21 
 
Infections  
Infections can lead to ulceration, which is slow to heal because of 
associated factors. Ex. cellulitis, thromophlebitis.  Primary streptococcal ulcer 
is rare, but streptococcus pyogens or staphylococcus aureus can complicate 
existing ulcer. Tuberculous cutaneous ulcer may occur in erythema 
induratum.
32 
 
Hypertensive ulcer (Martorell‟s ulcer)    
 
 Hypertensive ulcer was first described by Martorell and by Hines. 
Hypertensive ulcers are superficial ulcers with bilateral distribution.  Peripheral 
pulses are present. The ulcer is preceded by a small macular cyanotic lesion 
situated on the anterior external aspect of the leg.  It is seen in long standing, 
poorly controlled hypertensive patients.  Beta blockers should be avoided.
33 
 
Rheumatoid Arthritis/Vasculitis 
  
The leg ulcer develops on the shin or ankle after trauma, is related to 
vasculitis, and difficult to heal. Delayed ulcer healing is due to impaired 
mobility which contributes to poor muscle pump. The oedema is also difficult 
to control. Rheumatoid ulcers are due to rheumatoid arteritis. Ulceration of 
rheumatoid nodules is not common except at pressure points.
34 
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Ulceration due to Dermatitis Artefacta 
 This ulceration may be difficult to diagnose. Clinical suspicion can be 
raised by the following: 
 1. Unusual appearance and site 
 2. After trauma at work place with possible compensation issues 
 3. Angulate in shape  
 
 If any of history recurrence we can do biopsy to show up “out-side-in” 
damage, that is, disproportionate damage to the epidermis compared with the 
dermis.
31 
 
Pyoderma gangrenosum (PG) 
  
 Pyoderma gangrenosum is a non -infectious netrophilic dermatoses. It is 
rare condition and the diagnosis based on the clinical features and exclusion of 
other causes of ulceration. It can be associated with inflammatory bowel 
disease, thyroid disease, rheumatoid arthritis and leukemia etc.  Histo 
pathological features of PG are not diagnostic but can be helpful.
28 
Management of Chronic Leg Ulcer.   
Ulcer examination
 
1. Site 
2. Size 
3. Appearance 
4.  Base 
5. Exudates level 
6. Surrounding skin 
23 
 
 The surrounding region could be examined for edema, erythema, 
temperature, indurations, pigmentation, maceration, scars, hair pattern, 
gangrenous digits, cyanosis, capillary refill and varicose vein.
25 
 
Leg Examination  
1.  Palpation of peripheral pulses 
2.  To search for signs of venous hypertension Ex. Haemosiderin 
 pigmentation, stasis dermatitis, indurations, lipodermatosclerosis and 
 atrophic blanche 
3. To assess the range of hip, knee and ankle movements 
4. Sensation could be tested to rule out Hansean‟s disease and peripheral 
 neuropathy.
25 
 
Laboratory evaluation of leg ulcers 
1. Blood Investigations 
 i. Complete blood count and erythrocyte sedimentation rate: To rule out   
     infection, anemia and polycythemia 
 ii. Blood sugar level for diabetes 
iii. Liver function test 
iv. Renal function test 
       v. Serum transferrin, ferritin, vitamin A, C, zinc, iron – to rule out  
           nutritional deficiency. 
vi. Serum homocystiene levels 
 
24 
 
2. Laboratory test for Vasculitis 
Urine analysis for proteinuria, hematuria, antinuclear antibodies, 
rheumatoid factor,complement C4,circulating immune complexes, par proteins, 
immunoglobulin fractions, antineutrophil cytoplasamic antibodies, serological 
tests. 
 
3. Laboratory screening tests for clotting disorders 
 Activated partial thromboplastin time, prothrombin time, thrombin time, 
factor V(leiden) mutation, factor II mutation, antithrombin-III, protein C and 
protein S,and lupus anticoagulant, anticardiolipin 
4. Wound swabs for bacterial culture and sensitivity (level C) 
5. Tissue sample for mycobacterial and fungal cultures 
6. Wedge biopsies including ulcer margin and bed – to rule out malignancy, 
vasculitis and panniculitis (level D) 
7. Venous Doppler (Colour Doppler duplex ultrasound) 
8. Arterial Doppler is indicated in patients with ischemic rest pain, 
claudication, and impending gangrene. 
 When peripheral pulses are not palpable, Doppler flow meter is used to 
measure the pulsation over the dorsalis pedis and posterior tibial arteries Ankle 
brachial pressure index is calculated as follows (level D). 
                      Systolic pressure in the ankle 
ABPI =  
                   Higher of the two systolic pressure obtained from  
   Brachial arteries in both arms 
 
25 
 
9. Plain radiography of foot along with CT and MRI – To rule out 
osteomyelitis and malignancy 
10. Patch testing (level C): To rule out allergic contact dermatitis to 
medicaments and preservatives (when patient has been applying topical 
preparation for a long time.) 
 
Treatment  
Venous ulcers 
 First we have to exclude arterial disease. Primary aim of treatment is to 
reduce venous hypertension, promote wound healing and prevent recurrences. 
Venous hypertension may be reduced by simple leg elevation and compression 
therapy. 
 
Compression Therapy 
 The aim of compression therapy is to maintain sustained compression of 
30-40 mm HG at the ankle level thereby reducing the edema and improving 
calf muscle pump function and promoting ulcer healing. Multi-layered 
compression systems are more effective than single-layered compression 
systems. High compression therapy is more effective than low compression. 
Graduated multilayer high compression bandage regimens are the first line of 
treatment for venous ulcer without any complication with ABPI above 0.8
35 
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Types of compression devices 
1.  Graduated Elastic Compression stocking (level A) 
 According to European standardization commission compression 
 stockings are classified into four categories 
 
 Class I, 15-21 mm HG:  For thrombosis prophylaxis 
 Class II, 23-32 mm HG: Indicated in mild/moderate oedema, mild 
 chronic venous insufficiency, after sclerotherapy, pregnancy. 
 Class III, 34-46 mm HG: Indicated in severe chronic venous 
 insufficiency, severe oedema, lymphedema, post-thrombotic syndrome 
 Class IV, >46 mm HG: severe lymphoedema
36
  
 
2. Unna‟s Boot 
 Unna‟s boot contain zinc oxide 5 parts, gelatin 5 parts, boric acid 1 part, 
glycerin 8 parts and water 6 parts and ichthyol 1 or 2 parts. Moist gauze 
impregnated with this paste and it is wrapped from behind the first metatarsal 
up to an inch below the knee. It is applied in a figure-of-8 pattern or adding 
pleats while wrapping.  It may be left in place for 7 days before changing.
35
  
 
3. Four layered bandaging 
 It is a high compression bandage system that incorporates elastic layers 
to achieve sustained compression. 
Layer 1: Orthopaedic wool 
Layer 2: Cotton crepe bandage 
27 
 
Layer 3: Light weight class 3A elastic compression bandage  
Layer 4: Class 3B cohesive compression bandage and it retains the bandage in 
position. 
Class 3A: Maintain pressure up to 20 mm HG at the ankle level 
Class 3B: Maintains pressure up to 30 mm HG at the ankle level
36 
 
 
4. Intermittent Pneumatic Compression 
 It is mechanical method of delivering compression to swollen limbs. It 
will increase the venous return, increase the endogenous fibrinolysis, reduce 
the intravascular coagulation and improve the arterial perfusion. Relieves 
edema and promotes healing in venous ulcer patients. It is also used to treat 
lymph edema.
37 
 
 
Wound care 
Following modalities are practiced in wound care 
 1. Dressing (level A) 
 2. Debridement 
 3. Topical treatment 
 4. Systemic treatment 
 5. Biophysical treatment 
28 
 
1. Dressing 
 Dressing will maintain a moist environment which accelerates wound 
healing. Frequent application of saline dressings over the wound will helps to 
keep the wound surface moist, debrides the wound and removes the surface 
bacteria. 
 
 Active dressing deliver substances, such as growth factors which help 
for wound healing. Interactive dressings are occlusive dressing which provides 
a favourable microenvironment for the growth of new tissues. Occlusive 
dressings will control the exudates, infection and eschar is liquefied by 
autolytic debridement. 
 
Various type of dressing  
1. Films 
  They are thin transparent adhesives. They are made of polyurethane and 
should be changed every 12-24 hrs. Ex.Tegaderm. This kind of dressing 
protects the wound from contamination but can strip away the newly forming 
granulation tissue and used in wounds with moderate exudates. 
 
2. Hydrogels 
 They are gel like sheets and semitransparent. They are nonadhesive and 
should be changed every 1-3 days. Ex.Restore hydrogel. 
 
 
 
29 
 
3. Hydrocolloid 
 Dressing contains hydrocolloid with a polyurethane outer coating. 
Dressing should be changed once a week. Ex.duoderm 
 
4. Collagen 
It is available in particle and sheet form. It is obtained from human, 
porcine and bovine sources. It forms a biodegradable gel over the wound 
surface Ex.Promogran. This dressing will promotes wound healing by laying 
down a matrix which leads to new tissue formation and also depletion of free 
radicals and proteases 
 
5. Alginates  
 These dressings are biodegradable. They are derived from seaweeds.  
Alginates dressings can be left in place until soaked with exudates. Ex.sorbsan. 
They are highly absorbent and haemostatic and dry out the exudating wound 
making it more painful.
38 
  
 The skin surrounding the ulcer region may be damaged due to excess 
moisture, proteases and adhesives present in the dressings. So we can use 
barrier creams and ointments to protect the skin around the ulcer. 
Examples  
 1.Vaseline petroleum jelly 
 2.Unna‟s paste38 
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Debridement  
 Debridement will remove the necrotic debris and promotes the 
formation of healthy granulation tissue.  Various methods of debridement 
include: 
1.Surgical debridement  
2.Autolytic debridement 
3.Enzymatic debridement 
 4.Biodebridement 
 
Surgical debridement 
 By using a curette and scissors chronic wound is converted into acute 
wound which leads to neutrophils and macrophages recruitment. These cells 
secrete growth factors and phagocytise the bacteria and nonviable tissue.
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Bio debridement 
 Larvae of luciliasericata (“green bottle” blow fly) will selectively 
debrides the dead tissue and tissue debris by secreting collagenase.
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Enzymatic debridement  
 Application of topical protease preparation will target the fibrin and 
collagen of necrotic tissue. Ex.papain urea preparation obtained from papaya 
and collagenase derived from clostridium histolyticum.
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Autolytic debridement    
 By giving occlusive dressing, gentle separation of slough from wound 
bed will occur slowly in a moist wound environment. Proteases within the 
31 
 
wound space will liquefy the necrotic tissue and it is useful in patients with 
bleeding tendencies
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Topical treatment  
 Secondary bacterial infections will interfere with wound healing. So we 
can use topical antiseptic and antibiotics have been used to reduce the 
infection. 
Examples of various topical preparations are 
 1.Silver compounds: it is effective against gram negative bacterias 
2.Twenty percent benzoyl peroxide 
 3.Iodosorb 
 4.Metronidazole gel  - anaerobic coverage 
5.Retapamulin,mupirocin ointment  
 6.Modifieddakin solution 
 7.Neomycin and bacitracin should be avoided because of their contact 
 sensitivity. 
 8.Honey dressings are not recommended routinely.
41 
 
SYSTEMIC THERAPY 
1.Antibiotics 
In chronic leg ulcer patients, systemic antibiotics should not be used, unless 
there is clinical evidence of infection( level C) 
2.Pentoxifylline is used to increase microcirculatory flow but exact mechanism 
is not known(level A) 
3.Stanozolol: It is an  anabolic steroid  reduces the pain and dermal thickness 
in acute lipodermatosclerosis 
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4.Aspirin 
5.Micronized purified flavonoid fraction 
6.Mesoglycan 
7.Zinc
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SKIN GRAFTING 
1. Pinch Grafts 
 Pinch grafts are useful for small nonhealing ulcers with clean ulcer bed 
and healthy granulation tissue. It is a simple technique but cobble stoning of the 
ulcer site can occur.
42 
2. Split Thickness Skin Grafting: epidermis and portion of the dermis from 
the donor site is transferred to ulcer site. This graft covers large defects. 
3.Cultured Epidermal Grafts 
 Cultured epidermal cells(keratinocytes) can be derived from patients 
own skin(auto graft) or from donor(allograft) 
4. Dermal Substitutes 
 It is derived from human newborn foreskin fibroblast cells which are 
seeded on to a bio absorbable mesh. 
5. Composite Grafts( Apligraf) 
 It contains both dermal and epidermal components. It is a living 
bilayered skin substitute which is manufactured from neonatal foreskin 
keratinocytes and fibroblasts with bovine type I collagen.
43 
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Other therapies   
Biophysical modalities of treatment 
1. Electromagnetic therapy 
2. Low frequency ultrasound (34KHz) – temporary stimulation of 
microcirculation 
3. Negative pressure devices/vacuum assisted closure  -  sub atmospheric 
pressure of 100-125 mm HG is applied in a continuous or intermittent manner. 
4 .Hyperbaric oxygen therapy
44 
 
LASER FOR LEG VEINS 
1.Pulsed dye laser(PDL) 
For leg veins less than 0.2mm in diameter ,PDL laser 585nm and pulse 
duration 1-40ms is used. 
2. Diode Laser (800nm) 
Long pulsed Nd:YAG laser(1064mm),long pulsed alexandrite laser(755nm), 
intense pulsed light(515-1200nm) can be used for treating leg telangiectasias.
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Sclerotherapy  
 Introduction of a chemical (Ex. hypertonic saline, sodium tetradecyl 
sulphate, polidocanol) into the vein will induce endothelial damage which leads 
to thrombosis, subsequent fibrosis and occlusion. 
 
Endovenous techniques for varicose vein 
 1. Radiofrequency ablation 
 2. Endovenous laser ablation
46 
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Surgical methods for varicose veins 
1. Saphenofemoral ligation 
2. Great saphenous vein stripping 
3. Sub facial ligation of perforators 
4. Phlebectomies 
5. Subfascial endoscopic perforator surgery.  
 
TREATMENT OF ARTERIAL ULCER 
1. The patient should stop smoking and diabetes or hypertension must be 
well controlled. Lipid lowering drugs like statins, antiplatelet drugs like 
aspirin,clopidogrel and cilostazol (phosphodiesterase III inhibitor)  will 
prevent ischemic events.  
2. Regular graded exercise must be encouraged to promote development of 
collateral circulation. Pressure area must be protected. 
3. The head of the patient‟s bed should be raised by 4-6 inches to 
encourage gravity dependent arterial flow and limbs should be kept 
warm. 
4. If rest pain or acute infection is present patient must be referred to 
vascular surgeon. endarterectomy, balloon angioplasty ,femoral bypass 
graft may necessary in selected cases.
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Management of diabetic ulcer and neuropathic ulcers. 
The patient should follow this  instructions  
1. Patient should stop smoking 
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2. Regular inspection of the legs/feet for scratch mark,blisters,etc 
3.Wash the feet with Luke warm water daily and careful drying between    
the toes 
4. Use emollients 
5. Regular inspection of shoes and wear properly fitting shoes 
6. Avoidance of sandals and pointed shoes 
7. Do not walk bare foot 
8. Avoid walking long distance 
9. Report to doctor even for slightest foot complaints 
 Aggressive debridement of the dead tissue and the surrounding callus 
should be done. Occlusive dressing like alginates will absorb the exudates and 
maintain the moist environment. For ulcers will requires rest with foot 
elevation and if infection is severe, antibiotics can be given. Foot X-ray can be 
taken to rule out osteomyelitis of bone.  Osteomyelitis is commonest cause for 
nonhealing ulcer. Surgical intervention like wound debridement and removal of 
osteomyelitic bone will be done in this kind of ulcer. Once infection is 
controlled, adequate rest and offloading of the foot can achieve ulcer healing.
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History of patch testing 
 During 17
th
, 18
th
, 19
th
 centuries some researchers reproduced contact 
dermatitis by applying responsible agent to intact skin.   In 1847 Staedeler first 
described blotting paper strip method to demonstrate idiosyncrasy. In 1895 
Jadassohn described the role of patch testing in dermatitis medicamentosa and 
he is known as father of patch testing.
47
 Further establishment of patch testing 
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was contributed by Bloch, Bonnevie and Sulzberger. Standardization of patch 
testing has been contributed by Sulzberger.
48 
 
Eczema  
Eczema, a term derived from the Greek meaning „to boil‟.  It is a clinical 
and histological pattern of inflammation of the skin. It is seen in a variety of 
dermatoses with widely diverse aetiologies.  
 
Signs of Eczema: 
 Dryness, erythema, excoriation, exudation, fissuring, hyperkeratosis, 
lichenification, papulation and vesiculation. 
 
 
Histological features of eczema 
 Spongiosis, varying degree of acanthosis, hyperkeratosis, accompanied 
by lymphohistiocytic infiltrate in the dermis.
49
  
 
Classification of eczema  
 
 Eczema is broadly classified as exogenous and endogenous. External 
factors play a major role in exogenous eczemas. The term endogenous eczema 
implies that the eczematous condition is not due to exogenous   factors, but is 
mediated by processes originating within the body. Eczema can also be 
classified clinicopathologically as acute, sub acute and chronic.
50 
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Table - 4 
CLASSIFICATION OF ECZEMA
50
 
Exogenous eczema Endogenous eczema 
1.Irritant eczema 
 
2.Allergic contact eczema 
 
3.Photoallergic  contact eczema 
 
4.Infective eczema 
 
5.Eczematous polymorphic light 
eruption 
 
6.Dermatophytide 
 
7.Post-trauamtic eczema 
1.Atopic eczema 
 
2.Seborrheic eczema 
 
3.Asteatotic eczema 
 
4.Hand eczema 
 
5.Venous eczema 
 
6.Eye lid eczema 
 
7.Discoid eczema etc 
 
                                                                                                                  
Allergic Contact Dermatitis 
 It is a delayed hypersensitivity reaction which is caused by systemic 
exposure or ingestion of a contact allergen. It occurs in previously sensitized 
persons. 
History of patch testing 
 Von Pirquet coined the term „allergie‟ in early 20th century from the 
greek word allos and ergon.
51
 Contact allergy was first demonstrated by Bloch 
and Steiner.
52
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Pathogenesis of Allergic Contact Dermatitis  
 Jadassohn
53
 who described contact allergy in 1895, can be considered as 
the “father” of contact dermatitis. It is a type IV hypersensitivity reaction. 
Contact allergens are small-molecule substances of less than 500 daltons
54
, so 
they penetrate the skin barrier 
 
Fig 3 Pathogenesis of Allergic Contact Dermatitis 
                         
Path physiology  
Step 1 : Haptens penetrate the stratum corneum and binding of haptens to 
dendritic cells 
Step 2 : Hapten-carrying langerhans cells traverse through efferent lymphatic‟s 
to lymph node. 
Step 3 : Migrating langerhans cells are located in the Para-cortical area of the     
draining LN where they can present haptenated peptides on MHC class I and II  
molecules to CD8+and CD4+ T cells, respectively . 
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Step 4 :Proliferated T cells reach the blood flow through efferent lymphatics 
Step 5 : During this process they acquire skin-specific homing antigens (CLA 
and CCR4)and become memory T cells. Primed T cells preferentially diffuse in 
the skin after transendothelial migration. At the end of the sensitization step 
everything is ready for the development of a CS reaction upon challenge with 
the relevant haptens.  Elicitation phase: When the hapten is painted for a 
second (and subsequent) time, it diffuses through the epidermis and could be 
loaded by LC or other skin cells expressing MHC molecules, such as 
keratinocytes and dermal dendritic cells, which are then able to activate 
trafficking specific T cells  
Step 6 : CD8+ cytotoxicT cell activation initiates the inflammatory process 
through keratinocytes apoptosis and cytokine/chemokine production.(5) 
 
Patch Testing  
The „patch test‟ is the only practical test for demonstrating contact 
allergy at present.
56  
It is required to identify the cause of allergic contact 
dermatitis.  Some workers find patch testing to be of little value, while others 
believe that it is generally required to identify the cause of allergic contact 
dermatitis.  Patient selection, expertise in patch testing and criteria for 
relevance are among the factors accounting for their discrepancy. 
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 Properly applied and correctly interpreted patch test are, at present, the 
only „scientific proof‟ of allergic contact dermatitis. Patch test is a biological 
test to detect the presence of delayed type of hypersensitivity to specific contact 
allergens. The patch test is a unique direct “in vivo” test independent of any 
laboratory procedure.
57.58 
                                              
Predisposing factors for Allergic contact dermatitis 
Individual  
1. Constitution 
Sensitization depends upon the individual susceptibility.
59
Certain individuals 
are more sensitive to a particular substance. The role of atopy in allergic 
contact dermatitis is a matter of debate. One study reported high prevalence of 
contact allergy in atopic individual but another study showed same prevalence 
and others reported decrease in the prevalence of contact allergy.
60 
 
2.Sex 
  In one study, women were more susceptible whereas, in another study, 
men were more susceptible. The reason for the female preponderance is mainly 
explained by exposure.
61 
 
3.Race 
  Afro-Caribbean‟s are less susceptible compare with white people 
because of less exposure.
62 
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4.Hormones 
Amelioration or deterioration of contact dermatitis can occur during 
pregnancy.. Premenstrual exacerbation of contact allergy has been reported.
63 
5. Age 
   Positive patch test reactions tend to increase with age, due to exposure 
various allergens over a life time. Adults are more likely to have occupational 
or cosmetic allergies whereas old people are more liable to medicament.
64 
6.Contact dermatitis in children 
  Now a day‟s frequency of childhood allergic contact dermatitis has 
increased. The commonest allergens are nickel, fragrance, thiomerosal, 
medicaments, rubber chemicals and resins in footwear.
65 
7.Coincidental Diseases 
  Patients with debilitating disease such as cancer, hodgekin‟s lymphoma 
and mycosis fungoides have impaired capacity for contact sensitization.
66 
 
8.Medication 
  Medication can influence patch test reaction. Prednisolone (>15mg/day) 
and potent topical steroids suppress patch test reactions. Immunomodulators 
such as ciclosporin and azathioprine may reduce the intensity of patch test 
reactions.
67
 Therapeutic UVB or psoralen UVA therapy can also reduce 
allergic reactions.  
 
 
 
42 
 
9.Local factors.  
 Pre –existing or concomitant allergic or irritant dermatitis damages the 
skin, affecting its barrier function and producing increased opportunities for 
allergen absorption which leads to secondary sensitization. 
 
 Occlusion promotes percutaneous absorption and contributes to the 
high incidence of medicament dermatitis in stasis dermatitis, leg ulcers, otitis 
externa and peri anal dermatitis. Acquired sensitivity is more common if an 
allergens is applied to damaged skin.
68 
 
Factors that can enhance the risk of sensitization: 
1. Increased allergen absorption due to barrier disrupted skin. 
2. Recruitment of immune competent cells and cytokines which leads to 
priming of immunological response 
3. Accumulation of mononuclear cells. 
 
Matzinger‟s „danger model‟ concept for sensitization69 
 Contact allergy may develop in the presence of cytokine release from 
the keratinocytes which is provoked by a coexisting irritant or trauma. If there 
is no irritancy then tolerance will develop. 
43 
 
Environmental  
 Certain important environmental factors are 
1.Climate 
2.Flora and fauna 
3.Socio-economic and cultural 
 
1.Climate 
 UV exposure, heat and relative humidity ,may influence the liability to 
contact allergy.UVB exposure will diminish the skin‟s immune response to 
contact allergens, however reduction in immune responsiveness by UVA 
exposure is transient due to adaptive mechanism.
70 
 
Chapping of the skin during winter season  predisposes  to irritant 
dermatitis and increases the incidence of false-positive reactions to certain 
substances such as formaldehyde and propylene glycol.
71
 Occlusion and 
excessive sweating can increase contact allergy from shoes and clothing.  
 
2. Socio-economic and cultural 
 Exposure to cheap metals, various cosmetics and perfumes may vary 
according to social class. In the Middle and Far East, the traditional herbal 
medicines and balms are commonly used to treat skin disorders. In addition 
ingestion of herbal folk remedies can also cause systemic allergic contact 
dermatitis. Hair dyes, kumkum and bindi are commonly used by Indian 
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women.
72
 But various cosmetics and sunscreens are mainly used by Western 
people. 
 
3. Flora and fauna 
 Seasonal variations are most common in plant dermatitis. Many allergic 
plants especially compositae family plants are destroyed by cold and frosty 
weather but return during spring and summer season. Geographical location is 
an important influence. In India parthenium contact dermatitis is more 
common. 
  
 Fauna has only mild influence. European fishermen are liable to contact 
allergy of exposed skin only during the summer season due to handling of nets 
which contain bryozoans (marine organism).  This is known as „Dogger Bank 
Itch‟ in the United Kingdom. The identified allergen is (2-hydroxyethyl ) 
dimethyl sulfoxonium ion.
73 
Chemical  
 Skin cell molecules: Contain nucleophilic atoms  
 Haptenmolecules : Contain electrophilic atoms (positively charged, 
electron deficit)  
 
+ Hapten (<500-1000Da) 
 Covalent binding  
  
 
Skin cell 
Hapten protein complex or complete antigen 
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 Haptens are grouped according to their chemical reactivity or according 
to functional groups. Some haptens are not allergenic .but they are converted 
into allergenic molecule by the skin detoxification process (hydroxylation, 
monoamineoxidases, peroxidases)
74 
 
Table - 5 
CLASSIFICATION OF HAPTENS BASED ON FUNCTIONAL GROUPING
75 
1.Acids 7.amines 
2.aldehydes 8.esters 
3.diazo compounds 9.epoxides 
4.metals 10.halogenated compound 
5.ethers 11.quinones 
6.unsaturated compound  
 
Sensitization Potential  
 It is the capacity of a given allergen to induce sensitization in a group of 
humans or  animals. 
  
Various test procedures to assess the sensitization 
1. Maximization test(described by Kligman and Epstein) 
3. Open epicutaneous test 
4. The Draize test 
5. Freud‟s complete adjuvant test 
6. The local lymph node assay 
7. The mouse ear swelling test.
76 
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Patch Test  
Methods 
The basis of patch testing is to elicit a delayed type of hypersensitivity 
response by challenging already sensitized person to particular amount and 
concentration of allergen and assessing the degree of response. Champers or 
discs are used for patch testing. Non-occlusive, non-allergenic and non-irritant 
fixing tape should be used. If the fixing tapes peel off, the patch test should be 
repeated. 
 
 In patients with active eczema we should not carried out patch testing. 
The patch testing could be delayed until the test site has been clear (at least two 
weeks). Corticosteroids and other immunosuppressive drugs like methotrexate 
and azathioprine should be stopped before patch testing. It may reduce the 
positive patch test reaction. But prednisolone less than 15 mg will not reduce 
the positive patch test reaction.
77 
 
Patch testing could be delayed for 28 days following sun bathing. The 
patches should not be exposed to UV light including sun light.  Infants, young 
children may be patch tested when indicated, but number of allergens tested 
can be reduced.
78
Pregnant patients should not be patch tested because of 
adverse effects. 
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Principles of Patch Testing 
1. We should use only known substances in “standard concentration”. For 
unknown substances we can do open or “use” tests with controls 
2. In acute dermatitis we should not test 
3. Inform the patient to leave the patches on for 48 hours 
4. Inform the patient not to shower, get the back wet, or engage in sports. 
Heavy work should be avoided. 
5. Initial reading should be taken at 48 hours and further reading should be 
taken between 72 and 120 hours. 
6. It is difficult to distinguish irritant reaction from allergic reaction. 
Itching is more common in allergic reaction
79 
  
Open use test or provocative use test 
 This test is mainly used for non-irritating substances such as cosmetics. 
The suspected substance is rubbed onto normal skin in the antecubital fossa. It 
should be applied twice daily for 1 week, over an area approximately 3 cm in 
diameter. If no reaction occurs, the test can be considered negative. False 
negative reactions are common in this method. This test can be used to detect 
contact urticaria.
79 
 
Instructions to the patient 
1. Patch should be left in place for two days and two nights 
2. Patient should not take bath or wash or wet the back during this 
period 
48 
 
3. Patient should be instructed to avoid tight underclothes 
4.To avoid exercise or any heavy physical activity which causes 
excessive sweating 
5.To avoid friction or rubbing and lying on the back because patches 
will become loose 
6.To avoid scratching the patch test site. Report immediately if there is 
severe itching or irritation 
7.To avoid exposure to sunlight/UV light 
8.To come after 48 hours and 72/96 hours for patch test reading. 
 
Patch Test Vehicles  
 Certain allergens may be applied to the skin as they are. To avoid an 
irritant effect, they should be mixed or dissolved in a vehicle. The test 
substances should be soluble in the vehicle.  
Petrolatum is most commonly used vehicle. Other vehicles are water, 
alcohol acetone, methylethylketone and olive oil. Irritants such as chloroform 
and benzene must be avoided. Petrolatum may not be ideal in hot climates. 
Petrolatum allergic reactions are rare.
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Test Material 
Patch Testing Materials-Manufacturers 
Hermal, D-21462 Reinbeck Germany and chemo technique Diagnostics AB, 
Modemgatan 9,S-235 39 Vellinge, Sweden or from local distributors. 
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 Finn champers on Scanpor tape is commonly used to apply patch test 
allergens. They are available in strips of five and ten which consist of small, 
occlusive aluminium discs. Champers is mounted on non- occlusive tape.  
 
Other systems 
1.Square plastic champers(Van Der Bend champers) 
2.Oval plastic champers(Epicheck) 
3.AL test  system: made of aluminium foil covered with 
polythene.Allergens are adsorbed onto a centrally placed filter paper 
disc of 10 mm diameter.
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TRUE Test 
Thin layer rapid use epicutaneous test. Allergens are available ready to 
use form coated onto polyester patches in a hydrophilic vehicle. It contains 
only 24 allergens of standard series. It was introduced by Torkil Fischer and 
Pharmacia. It is a convenient and portable method.
82 
 
Patch Test Concentration 
Suitable concentration is used for patch testing. Excessive concentration 
will result in false-positive reactions due tom their irritant effect whereas low 
concentration will produce false-negative results. We should not apply any 
unknown chemicals or substances.  
 
50 
 
The precise nature of the material should be decided by questioning the 
patient and examining the product label. If a positive reaction to an unknown 
substance occurs, it should not consider as allergic reaction. For unknown 
substance we can use open use test.
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 Test  dose 
1. Finn champers: 20 mg of allergen (petrolatum vehicle)
 83 
2. Disposable syringes (container): 5 mm length of test substance 
(petrolatum). 
3. Filter paper champers: 15 micro Ls (fluid vehicle) 
4. TRUE test: patches are pre-prepared
 
 
Patch Test Site 
 Back is the preferred site to apply patch test.  Allergic and irritant 
reactions are easily provoked on the upper back. Less suitable sites for patch 
testing are lateral aspect of arm, fore arm, abdomen and thighs.  
Table - 6  
Reactivity of various test sites
84 
Test site Irritant reactions (%) Allergic reactions (%) 
Upper back 100 100 
Upper arm 52 72 
Lower back 50 95 
Fore arm 38 74 
Thigh 36 50 
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Allergens Storage 
 Allergens should be stored in the dark in a refrigerator at 4 degree C. 
Certain allergens are unstable if exposed to light. Commercial preparations are 
labelled with expiry date. If they are not refrigerated properly, homogeneity of 
allergens may be lost. Rubber pipette caps contaminate the solutions and can 
cause false-positive patch test reaction in persons sensitive to rubber. 
 
Exposure Time 
 The mere touch of  some allergens can provoke a bullous response in a 
sensitive person, but some substances even 120 hours of occlusive patch tests 
can lead to false-negative results. For a well -established allergens, generally 
48 hours application time is needed. Reading will be taken 1 hour after removal 
of patch. Second reading will be taken after 48hous. Some authors have 
suggested that a Day 5 second reading is better. A single 48hours reading is not 
advised. If only one test reading is possible, a 96 hours reading has been 
recommended. Neomycin and corticosteroids are liable to give late reactions.
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Marking  
 Patch test sites are marked with indelible ink or stratum corneum stains. 
For dark skin we can use fluorescent marking. Marking materials are obtained 
from allergen suppliers.  
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Patch Test Reading and Interpretation 
Recording of patch test reading is done according to the International 
Contact Dermatitis Research Group criteria
86
  
 
Drawbacks of ICDRG System 
 It confuses morphology with interpretation. 
 
Relevance of patch tests
87 
Certain allergen has been demonstrated reliably by careful patch testing 
does not prove that such allergen was responsible for the dermatitis. The 
negative patch test does not prove the absence of allergy. Relevance may be 
considered possible, probable, or certain. 
 
Following questions may be helpful for determining relevance 
1. Relevance to the Present Dermatitis 
i. Primary cause 
ii.Aggravating factor 
2. Relevance to a Preceding Bout of Dermatitis 
i. Primary cause  
ii.Aggravating factor  
3. Not Relevant 
 
The strength of patch test reaction depends upon the following factors
88 
1. Barrier function 
2. The presence or absence of sweating 
53 
 
3. The atmospheric humidity 
4. Test material 
5. Technique 
6. The reactivity of the individual. 
 
Irritant Patch Test Reaction
87 
Causes for irritant patch test reactions 
1. Hyperirritability of the skin 
2. Application of an irritating concentration of a test substance 
Spill over  
One positive test has influenced another test to appear positive. 
 
Certain rules must be followed to avoid irritant reactions
87 
1. Patch testing should be carried out only on the normal skin 
2. Irritating concentration of test materials should be avoided\ 
3. Cleansing the skin with soaps or solvents should be avoided 
4. Avoid patch testing with nonstandard substances other than standard 
series 
 Janus reaction 
87 
 
It is a non papulo vesicular patch test reaction consisting of palpable 
erythema and oedema. The significance of these reactions may be determined 
over time, based on patient‟s outcome. This mild reaction may or may not be 
relevant, so further correlation is needed to establish contact allergy. 
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Irritant reactions are liable to induce stronger reactions at 48 hours than 
at 96 hours. This is called crescendo-decrescendo effect. 
 
Non- invasive measurement techniques
89 
1 .Laser Doppler flowmetry 
2. Replica techniques 
3. High-frequency ultrasound 
4. Skin reflectance 
5. Transepidermal water loss 
6. Thermography 
 
Causes of false positive patch test reactions
88 
1. Excessive concentration of allergens 
2. Impure patch test substance 
3. Excessive amount of allergen applied 
4. Vehicles may be irritants 
5. Hard material can cause pressure effect 
6. Uneven dispersion of allergen 
7. Active or recent dermatitis at patch-test site 
8. Active dermatitis at distant site 
9. Artefact 
10 .Irritant reaction due to adhesive tapes 
11. Angry back reaction 
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In case of any doubt, we can repeat the patch test  some weeks later. 
Usage test or ROAT test is used to differentiate allergic reaction from  irritant 
reaction. 
Causes of false negative patch-test reactions
88 
1. Insufficient concentration of allergens 
The threshold or reactivity has narrow margin so, the concentration of 
allergen is critical and should be standard. 
2. Improper adhesion of patches 
3. Patches are applied at wrong site 
4. Inadequate amount of allergens applied 
5. Pre treatment of test site with topical corticosteroids 
6. Inappropriate vehicles may be used 
For example, testing with nickel in petrolatum produce negative 
reaction, whereas testing with nickel in an aqueous solution produce 
positive reaction 
7. Substance may degraded 
8. Too early reading 
When patch tests are read at Day 2,some positive reactions are  missed. 
Ex.Neomycin and corticosteroids 
9. Systemic treatment with immunosuppressant‟s such as cyclosporine, 
azathioprine 
10. UV irradiation of test site 
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Sometimes a patch test fails to produce a positive reaction in a sensitized 
person. The most common cause of false-negative reactions is poor penetration 
through the skin. Neomycin and corticosteroids will take long period of 
latency. So late reading should be preferred for this substance. false negative 
reactions are common with textile allergens, cosmetics, cutting oils, washing 
materials, medicaments, leather and rubber. Sukanto and associates reported 
that the topical application of corticosteroids has a suppressive effect on both 
the intensity and the size of reaction.
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Dermatologist hesitate to use patch testing because of following four reasons 
1. The amount of time required of the dermatologist 
2. The number of visits required of the patient 
3. Suitable test materials are not available 
4. The risk of patch test complications
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Complication of patch testing 
1. Active sensitization 
A patch test reaction appearing seven or more days after application of 
patch may denote either delayed expression of a pre-existing sensitivity or 
sensitization from the patch testing. Active sensitization presents as a strong 
positive test occurring at around 3 weeks. 
 
 The most common cause of sensitization is the use high concentration of 
the test substance. So patch testing with standard allergens may not produce 
sensitization. Sometimes persistence of test reactions can continue for several 
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weeks. Ex.gold sodium thiosulphate. Sensitization is common when patch 
testing with unrefined wood or plant or patients own material.
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 Cronin clearly states “active sensitization is a complication of patch test 
but it is not a hazard. It should not be used as an excuse by the indolent for 
eschewing this investigation. To reject patch testing is the greater disservice to 
the patient” 92 
 
 
2. Edge Effect 
The reaction is more at the periphery of the patch test but at the centre 
there is little or no reaction. This called as edge effect. Edge effect is due to 
increased concentration of liquid which act as an irritant. The edge effect will 
disappear following removal of the patch. However the edge effect which is 
produced by corticosteroids is different. This edge effect is a sign of allergy 
and denotes interaction between pharmacological and immunological activity 
of corticosteroids. Lower concentration of corticosteroid gives positive patch 
test.
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3. Irritant patch test reactions 
 Irritation may be avoided by using standard procedures. Substances 
should be investigated toxicologically and allergologically. 
 
4. “Ectopic” Flare of Dermatitis 
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5. Persistence of a Positive Patch Test Reaction 
Contact dermatitis to gold is known to persist for more than a month. To 
control this reaction we can use intralesional corticosteroids.
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6. Koebner Phenomenon  
A positive test reaction in a patient who is having psoriasis or lichen 
planus may reproduce these dermatoses at the test site. This is known as 
Koebner Phenomenon. 
 
7. Alteration in Pigmentation 
Hyperpigmentation from patch tests may occur in darkly pigmented 
persons. Topical corticosteroids are used to treat this hyperpigmentation. 
Hydroquinone should be avoided. Severe positive reactions can cause 
hyperpigmentation or total depigmentation. Irritant reactions may cause 
hyperpigmentation.
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8. Anaphylaxis 
Anaphylactic reactions from patch tests are rare manifestation. 
Anaphylactoid reaction can occur within 30 minutes after application of topical 
antibiotics such as penicillin, gentamycin, neomycin and bacitracin. Nitrogen 
mustard can also cause anaphylaxis. 
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9. Pustular Patch Test Reactions 
This reaction can occur from application of nickel and copper sulphates, 
arsenic trioxide, and mercuric chloride.
93 
10.Bacterial and viral infections 
This is very rare side effect. This can occur in patients who are patch 
tested with fresh plants. In mayo clinic one case was reported.  A patient who, 
after being tested snapdragon plant, developed a necrotizing cellulitis at the test 
site due to a mucormycosis with Apophysomyceselegans.
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11.Pruritus 
12.Pressure effect 
Application of solid substance to the skin may produce an oedematous 
area which is most intense at the margins. This reaction is more common in 
persons who have a tendency to develop dermographism 
13. Leakage of material on to the clothing, especially dyes 
14. Folliclitis 
16. Localized flare of dermatitis and other skin disorders 
17. Generalised flare of dermatitis 
18. Flare of dermatitis at previous contact site 
19. Necrosis, scarring, and keloids 
Hypertrophic scar formation is a rare complication and it is usually 
associated with very strong patch test reaction. 
20. Milia
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Angry Back Syndrome 
During active dermatitis uninvolved skin also exhibits increased 
susceptibility to irritant reactions which lead to multiple false positive patch 
test reactions that is „eczema creates eczema.‟ It is also known an excited skin 
syndrome or crazy back syndrome
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Spot tests 
1. Acetylacetone method for formaldehyde 
Reagent :15 g of ammonium acetate + 0.2 ml of acetyl acetone+0.3 ml 
of glacial acetic acid in 100 ml of distilled water. This reagent should be stored 
in a refrigerator. The test product is put in a disposable glass test tube and 2.5 
ml of the reagent is added. The mixture is shaken and then placed in a water 
bath at 60 degree C for 10 min. If formaldehyde is present yellow colour will 
be produced.
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2.Dimethyl glyoxime is used for nickel spot test. 
 Migration inhibition test, lymphocyte transformation test and leukocyte 
procoagulant activity are the invitro tests used to detect contact allergy.  
 
 
Open Tests 
The liquid test substance is applied on the skin (1cm area) and it is 
allowed to dry. Then reading will be taken at 48 hours and 72 hours. The risk 
of severe reactions is less, so it is mainly used as a screening procedure for less 
well known substances.  
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Usage Test` 
 If an open patch test or closed patch test is negative but patients history 
suggests a contact dermatitis we can perform usage test. 
Repeated  Open Application test (ROAT) 
The test substances are applied twice daily for up to 28 days or until an 
eczematous reaction develops. The preferred test site is the upper arm or flexor 
surface of the forearm. An area of five cm2 should be employed.
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Intradermal Tests 
Intracutaneous tests have been performed with simple chemicals, but it 
is mainly used for investigational purposes. This technique has proved reliable 
for nickel and corticosteroid allergy.
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Leg Ulcer Series Allergens 
01. Control 
02. Amerchol L 101 
Amerchol is a trade name of product containing lanolin alcohol. It is 
obtained from hydrolysis of lanolin. Amerchol L 101 is a concentrated 
absorption base composed of lanolin alcohols and mineral oil. 
 
Amerchol  is  an  emulsifier  and  emollient  in  cosmetic  and 
pharmaceutical  bases, topical  drugs.  It  is  also  found  in   furniture  polish,  
leather,  metal  corrosion  prevention,  paper inks, textiles,  furs,  cutting  oil  
and  waxes. 
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Because  of  its  ability  to  penetrate  the  epidermis  to  the  depth  of  
the  stratum  granulosum  and  into  the  keratinocytes,  lanolin   has  been  
prescribed  for  the  treatment  of many  skin  conditions, including  xerosis, 
eczema  and  nipple  eczema  in  lactating women  
 
 Mortenson conducted a study, in this study 899 patients were patch 
tested with wool alcohols, hydrogenated lanolin, Eucerin, and AL-101.
98
out of 
899 patients, 6.7% of patients were positive to at least one of these allergens. A 
Belgian study showed contact allergy to Amerchol L 101.
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Cross Reaction 
Wool alcohols, Lanolin, Wool fat 
Other names:  Lanolin alcohol, Wool alcohol  
  
Lanolin Paradox 
In 1996, Wolf used the term “lanolin paradox”. 
1.  Medicaments  containing  lanolin  may  sensitize  patients, especially    
those   with  eczema   ,whereas  lanolin-containing  cosmetics  are    less  
sensitizing. 
2.  Lanolin –containing medicaments will cause contact allergy when applied to 
ulcerated skin, but those same patients can not develop reaction to lanolin-
containing cosmetics. 
3.  Lanolin-sensitive patients have negative patch-test reaction to pure lanolin: 
this can be due to a low concentration of allergens. 
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4.  Wolf concluded that using only a paraben mix is not a reliable method to 
test for paraben contact allergy, the use of only 30% wool alcohol to test for 
allergy to lanolin is insufficient
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03.  Fusidic acid sodium salt: 
  Fusidic  acid  sodium  salt  is  an  antibiotic  agent  used  in  the  
treatment or  prevention  of  cutaneous  infection. It is mainly used for 
staphylococcal infection. 
 
       Sensitization to fusidic acid sodium salt may occur from its use on stasis 
ulcers.  DeGroot reported  a  case  of  stasis  ulcer  with   allergic  contact  
dermatitis  due  to topical  treatment  with  sodium fusidate ointment
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       It  is  a  bacteriostatic  antibiotic  which  inhibit  protein  synthesis. Fusic 
acid sodium salt 2% in petrolatum is used for patch testing. 
Indian brand names: 
 
1. Fucidin cream/ointment - fusidic acid 
2. Fucibet cream   - fusidic acid + betamethasone 
3. Bactirest-M cream   - fusidic acid +mometasone furoate 
4. Metos F ointment   - fusidic acid + mometasone furoate 
5. Fuzap cream   - fusidic acid 
6. Foban ointment   - sodium fusidate 
7. Fusic cream - fusidic acid 
8. Clonate-F cream    - clobetasol + fusidic acid 
9. Fucidin- H cream – fusidic acid + hydrocortisone acetate  
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04. Chlorhexidine digluconate   
       Chlorhexidine chemical structure is 1.1-hexamethylene bis 5(P 
chlorophenyl) biguanide. It   is an antibacterial compound.  It  is  active  against  
gram positive  and  gram  negative  bacteria  even  in the  presence  of  body  
fluids. 
 
Most frequently used chlorhexidine salts are digluconate, acetate, and 
diacetate.   Nepal  is  the  first  country  in  the  world  to  use  topical 
Chlorhexidine. 
     
Chlorhexidine is used as a surgical scrub, hand rinse and topical 
antiseptic. It should be used with caution on wounds caused by disturbed 
circulation. 
     
The use of chlorhexidine on mucous membranes has been discouraged 
as it poses a risk of anaphylaxis. A woman cut her foot on broken glass.  She 
applied a chlorhexidine disinfectant to the broken skin site.  Within a minute 
she had urticaria, angioedema, wheezing, dizziness, vomiting and diarrhoea. 
     
 Urticaria and dyspnoea can occur if it is used for insertion of an 
intrauterine device.
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 Chlorhexidine is biologically allergologically active in aqueous 
solutions only. So  false  negative  patch  test  was  obtained  when  
chlorhexidine  was applied  in  petrolatum.  The ideal test for chlorhexidine is 
uncertain. 
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Chlorhexidine digluconate brands in India 
1. Aloederm –B cream - Chlorhexidine Gluconate, Allantoin, Aloe 
Vera, Silver Sulphadiazine,  
2. Savlon liquid – Chlorhexidine + cetrimide 
3. Silverex cream – silver sulphadiazine gluconate+ chlorhexidine 
4. Quadragel- lidocaine +metronidazole+chlorhexidine 
5. Bactigauze plus dressing – chlorhexidine+silver sulphadiazine 
6. Burnheal ointment 7.C.S.S cream 8.Clohex plus -mouth wash 9.Drez-
S dressing 7.Heelcare cream 8.Metro gel 9.Orahex gel 10.Microgard 
Tulle 11.Silivindon plus cream. 
 
05. Benzalkonium chloride 
     Benzalkonium chloride is a mixture of alkyl dimethyl benzyl 
ammonium chlorides. It is a quaternary ammonium cationic detergent. It is 
used as a preoperative skin disinfectant, for disinfecting surgical instruments. 
        
Benzalkonium chloride is also used in the treatment of burns, ulcers, 
wounds, and infected dermatoses. It is found in many cosmetics, deodorants, 
dentifrices, mouth washes, lozenges and ophthalmic preparations. 
  
It is used in the fabrication of textiles and dyes and in metallurgy and 
agriculture. It can cause cutaneous and mucous-membrane allergic contact 
dermatitis. 
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        Lovell and Staniforth reported a case of allergic contact dermatitis due 
to the presence of benzalkonium chloride in plaster of paris.
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Cross reactions:  cetrimonium bromide, benzethonium chloride. 
Benzalkonium brands in India 
1. Happynap cream- bezalkonium chloride+zinc oxide 
 2. Oilatum plus lotion – light liquid paraffin+BZK 
3. Rashfree cream – zinc oxide + BZK 
4. Bonzela ointment-choline, salicylate, lignocaine, BZK 
5. Lacrisan eye drops-povidone iodine+ BZK 
6. Orex cream- tannic acid+menthol+choline salicylate+BZK 
7. Ulceheal gel-choline salicylate + BZK. 
8. Ofelder eye/ear drops-ofloxacin +methyl cellulose+BZK 
 
06. Nitrofurazone 
Nitrofurazone is a topical antibiotic.  It is also used in animal feeds and 
in veterinary medicine. It is available as nitrofurazone dressing, soluble powder 
and topical cream. Nitrofurazone is globally banned but it is available in India. 
        
Nitrofurazone is a well known sensitizer. It is used extensively. It can 
cause severe allergic contact dermatitis. Patient who had ulcer with stasis 
dermatitis are particularly prone to sensitization.
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In one study 58 patients were sensitized by medicaments containing 0.2 
% nitrofurazone. Most of the patients had stasis dermatitis or ulcer and re 
exposure to nitrofurazone had caused a generalized eczema in some patients. 
       
Nitrofurazone soluble dressing can also produce allergic contact 
dermatitis when it is applied to a second degree burns of the leg..Nitrofurazone 
dressing and powder contain polyethylene glycols. Allergic reactions may 
occur either from nitrofurazone or the polyethylene glycols.    
 
Nitrofurazone brands in India 
Furacin ointment, Furacin cream, Furacin powder, Furacept cream, 
Decain cream, Emfurazone cream, Furocid ointment, Nitrofurazone gauze 
dressing, Nitraheal TM dressing. 
 
07. Bacitracin 
Bacitracin is a polypeptide antibacterial agent. It is produced by the 
Tracey 1 strain of Bacillus subtilis.  It inhibits bacterial cell wall synthesis. It is 
active against gram positive organisms and spirochetes. It can be combined 
with polymyxin B, neomycin to provide a wide spectrum of bacterial coverage. 
 
Adverse effects due to topical application of bacitracin are localized 
itching and burning. It is a frequent allergen in patients with chronic stasis 
dermatitis and conjunctivitis. 
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Bacitracin is a sensitizer. Topical application can produce anaphylactic 
shock. Polymyxin B sulphate can cross react with bacitracin, because both 
antibiotics are obtained from Bacillus subtilis. Bacitracin can “co-react” with 
neomycin. Most of the topical bacitracin preparation contains neomycin and 
Polymyxin. 
Bacitracin(Indian Brands) 
 Derbec-N cream – beclomathasone dipropionate + neomycin sulphate + 
bacitracin 
 Nebaspor  ointment and powder – polymyxin + bacitracin + neomycin 
sulphate 
  Nebasulf skin ointment 
 Neosporin powder, Neosporin skin ointment –polymyxin +bacitracin + 
neomycin sulphate 
 Neosporin –H ointment  
 Neotop powder -Bacitracin Zinc+ Neomycin Sulfate + Sulfacetamide  
 Polybanetm tulle dressing–polymyxin + bacitracin + neomycin sulphate 
 
08. Cetyl Stearyl Alcohol (Lanettee O) 
      Chemical formula for cetyl alcohol is CH3 (CH2)14 CH2 OH and for 
stearyl alcohol is CH3 (CH2)16CH2 OH. Both alcohols are often used 
together. They are used as an emulsifier and stabilizer 
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 Both alcohols 50/50 are used as an emulsifier and emollient in cosmetic 
lotions, creams, ointments and pharmaceutical preparations.  
       
Persistent urticarial plaques are the morphological presentation of 
chronic dermatitis. Cetyl stearyl alcohol can cause persistent urticarial plaques. 
Contact allergy is rare with this compound. 
 
    Usually there should be a predisposing factor that increases patient 
sensitivity.  One patient had developed contact allergy to stearyl alcohol in 5 –
fluorouracil cream. This is due to irritant effect of 5 –FU which predisposed to 
ACD develop.
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Sources  
Moisturisers, antifungal, acne and steroidal creams, sunscreen, 
medicinal soaps, detergents, textile oils. 
 
Example (Indian brands) 
1. Moisturizers 
Cetaphil  lotion   and  cream, Cetaphil  cleansers,  Cetaphil  
moisturizers, Cetraben cream, Dermadew lotion,Venusia max,Papulex 
cream. 
2. Antifungal Cream 
Candid cream 
Nizoral cream 
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3. Topical Steroids   
 Betnovate C and N creams –betamethasone valerate. 
 Betnovate lotion 
 Elocon cream-momatesone furoate 
 Momate ointment 
 Fucidin H cream and ointment –fusidic acid+hydrocortisone 
 
09.2,6 Ditert-butyl 1-4-cresol (BHT)  
      2,6  Ditert-butyl-4-cresol is a butylated hydroxyl toluene.  It is one of 
the most commonly used antioxidants in both foods and topical preparations. It 
is also used in the production of petroleum based products ( eg.plastic, rubber, 
and fuels), as well as in animal feeds. 
 
BHT has antibacterial effects; particularly active against 
corynebacterium sp. Prevalence of allergic contact dermatitis due to this agent 
is low. 
Indian brands with BHT 
Atlargo ointment – BHT +retapamulin 
Tretin cream – tretinoin cream 
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10. Chloramphenicol 
         Chloramphenicol  is an antibiotic and anti rickettsial substance produced 
by streptomyces venezuelae.  It is act as bactericide against the rot of potatoes 
and other root vegetables.  
         One patient had two episodes of contact conjunctivitis and dermatitis of 
the lids due to application of chloramphenicol eye drops.
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Allergic contact sensitivity to this antibiotic is rare. Schwank and Jirasek 
reported contact allergy to chloramphenicol applied to stasis ulcers and 
eczemas. It can cross react with Azidamphenicol. 
Chloramphenicol (Indian brands) 
Chloromycetin drops, Dexamon drops, Solubin-c ointment, Chlorocol 
eye ointment. 
 
11. Benzoyl peroxide 
       Benzoyl peroxide is used for treatment of leg ulcer. It may cause 
discoloration of hair.
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 It will mainly cause irritant reactions. allergic reaction 
to this agent is rare. 
      
It is used to bleach candles white.  It is an air borne contact ant.  
Exposure  to burning candles  in a church has caused facial dermatitis.  
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Benzoyl Peroxide Uses 
1.Topical acne preparation 
2.Additive to self-curing acrylic 
3.Bleach for flour and oil 
4.Stasis ulcer treatments 
Acne preparation brands in India 
Benzac AC gel, brevoxyl gel, pernox gel, persol gel. 
 
12. Propylene Glycol (Pg) 
 
          Propylene glycol is a  dihydric alcohol,CH3CHOHCH2OH. It is an 
odourless, viscous liquid. It is readily miscible with water, acetone, chloroform 
and essential oils. 
 
        PG is stable under ordinary conditions. It is very hygroscopic, with an 
isotonic concentration of  2% in water. It is used  as a vehicle for topical         
therapeutics, cosmetics, and  body lotions.  
 
      It is an antibacterial and antifungal. It acts against Escherichia coli, 
Pseudomonas and other bacteria, as well as Candida albicans, Bityrosporum 
orbiculare and some Dermatophtes.  PG does not cause follicular 
hyperkeratosis and is therefore non comedogenic.
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  PG is also used in automotive brake fluid and antifreeze formulations, 
alkyd resin manufacture, as a plasticizer for some resin systems. It is a solvent , 
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humectants, inhibitor of fermentation, preservative, softening agent and a heat 
–transfer fluid for the processing of foods. 
 
Undiluted Propylene glycol can be a skin irritant. Irritant effects of PG 
are more on atopic patients and those who have eczematous dermatitis.  Irritant 
response to PG may be more frequent in winter. 
 
   Most of the steroid preparations contain PG to enhance the penetration 
and thus the efficacy of the corticosteroids. It is also used as a preservative in 
topical preparations. 
 
Examples of Indian brands which contain propylene glycol 
1.Moisturizers  
Cetaphil  lotion, venusia max, venusia lotion, venusia cream, 
dermadew lotion, moisture cream 
2.Antifungal  
Nizral cream 
Onabet lotion. 
3.Topical Steroids 
 Momate ointment 
4.Sunscreen 
Ansolar sunscreen 
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13. Propolis (bee glue) 
 
Propolis is a dark yellow-brown resinous substance found in beehives.  
It is collected by bees from poplar buds. It contains cinnamic acid and vanillin 
which is known sensitizers. 
 
It is used in the treatment of leg ulcer because it composed of a mix of 
essential oils, pollens and a variety of polyphenolic compounds (flavonoids, 
phenolic compounds). Polyphenolic compounds are antioxidants. 
 
 It is found in bio cosmetics, face creams, ointments, lotions, solutions, 
varnish, toothpaste, mouthwashes, tablets, chewing gums. It is also found in 
wax for violins. It is used in homeopathic medications. 
 
 Propolis may cross react with balsum of Peru. Allergic contact 
dermatitis due to propolis is an occupational hazard for beekeepers. 
 
Cross reaction: Balsum of peru. 
 
14.Thiomerosal  (merthiolate) 
  Thiomerosal is an organic mercurial compound. It is used as an 
antiseptic .It is also used as a preservative in topical medicaments, contact lens 
solutions, eye drop solutions, cosmetics and vaccines. Thiomerosal contains 
two distinct radicals: an organic mercury compound and a thiosalicylate. 
Thiosalicylate compound is a strong sensitizer. 
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It is used as a preservative in vaccines, antitoxins, parentral medications, 
and diluting fluids used for preparation of antigens for scratch or Intradermal 
testing. Thiomerosal can produce life –threatening reactions. Thiomerosal is 
commonly found in hepatitis, tetanus and meningoencephalitis vaccines. 
 
Thiomerosal sensitive patients can be divided into three groups: 
1. Positive to Thiomerosal but negative to thiosalicylic acid and to other 
mercury compounds. 
2. Positive to Thiomerosal and to some other mercury compounds. But 
negative to thiosalicylic acid 
3.Positive to thimerosal and to thiosalicylic acid but negative to other 
mercury compounds 
 
 Thiomerosal is used as a preservative in contact lens solution and eye 
drop solution which can cause conjunctivitis and eyelid dermatitis. In one 
instance, a sensitized person had hand dermatitis without conjunctivitis. 
 
 A patient with Thiomerosal sensitization had developed allergic contact 
dermatitis over the fingers and palms; however when this same solution was 
applied to the eyes, it did not produce eye lid dermatitis.
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Cosmetic products with thimerosal 
Fair & Lovely, Fair & Handsome, GarnierLite, Olay- products with 
thiomerosal. 
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Indian brands with thiomerosal 
Vaccines 
Tripedia –DTaP vaccine 
Fluzone –seasonal trivalent influenza vaccine 
TT vaccine. 
 
15.Sorbic Acid 
Sorbic acid chemical name: 2,4-hexadienoic acid and 2-propenyl –
acrylic acid. 
Chemical formula : C6H8O2 
Sorbic acid is obtained from the berries of the mountain ash, Sorbus 
aucuparia, L.rosaceae.  It is found incranberries, strawberries and is used as a 
preservative in many foods. 
 
It is used as a preservative in cosmetic and pharmaceutical products. It is 
also used in alkyl coating and drying oils, adhesives, glues, inks, paints, 
varnishes, tanning agents, metal working fluids. 
 
It is a white, odourless, crystalline powder with a faintly acid taste. 
Potassium sorbate  is a salt form of sobic acid. It is also a white odourless 
powder. It  is soluble  in water, alcohol and propylene glycol. It has excellent 
fungi static activity and with little antibacterial activity. 
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Allergic contact dermatitis due to sorbic acid is rare. Clemmensen and 
Schiodt   reported that sorbic acid in the particular concentration, when used as 
a preservative is not urticariogenic.
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Allergic reaction can occur if it is inhaled, ingested or in contact with 
skin. Inhalation of pure sorbic acid should be considered as a medical 
emergency. 
 
Sorbic acid can produce an immediate nonspecific erythema. topical 
agents that can produce immediate nonspecific erythema include benzoic acid, 
sodium benzoate, MP, cinnamic aldehyde, cinnamic alcohol and ethyl vanillin.  
 
Cross reaction : potassium sorbate. 
Potassium sorbate containing preparations 
Nizral cream- ketoconazole cream 
Pramosone cream-hydrocortisone cream 
Fucidin H cream –fusidic acid + hydrocortisone 
 
16.Eosin 
Eosin is a red dye belonging to the xanthenes group. Back in 1920-30s it 
was used in high concentrations in lipsticks. It is also used as a colouring agent 
in nail polish, wool.  Silk and paper. It is now approved by the FDA for use in 
inks. 
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17.4-chloro-3-cresol 
Chemical formula:C7-H7-CL-O 
Chemical name:4-chloro-3-methylphenol 
 Chlorocresol is a chlorinated phenol. It is used as an antiseptic agent, 
disinfectant, antifungal agent and anti- bacterial agent. It is also used as a 
preservative for various creams, lotions, cosmetics, glues, gums, paints, inks, 
textiles and leather goods. 
 
 Chlorocresol is found as white or slightly pink dimorphous crystals that 
have a phenolic odor. It is toxic to wild life, water –dwelling organisms. It is 
active  against gram positive and gram negative bacteria, fungi but little 
activity against bacterial spores except at high temperature. 
 It is more active in acid than in alkaline solution. It can cross react with 
parachlorometaxylenol. chlorocresol is an infrequent sensitizer. Of 1000 
patients who had contact dermatitis analysed by burry and colleagues, only 11 
patients reacted to chlorocresol.
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Dermatitis from chlorocresol in betamethasone creams were reported in 
13 patients.
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Chlorocresol in Indian creams 
1.Topical Steroid Creams 
 Tenovate cream- clobetasol propionate 
 Eumosone cream-clobetasone 
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 Betnovate-N cream, betnovate–M cream, Betnovate-GM cream, 
betnovate-C cream 
 Betanil cream-betamethasone 
 Bactoderm –N cream –betamethasone +neomycin 
 Clonate –G cream – clobetasol+gentamycin 
 Cosvate-GM gel- clobetasol+gentamycin 
 Sonoderm – M cream-clobetasol+ micanozole 
 Fucibet cream –fusidic acid +betamethasone valerate 
 Anovate cream – beclomethasone dipropionate+phenyl ephrine 
hydrochloride. 
 
Topical corticosteroid cream free of chlorocresol 
 Dexomet cream - desoximetasone 
 Flutivate cream -fluticasone 
 Momate –F cream –mometasone 
 Halox cream – halobetasol propionate 
 
18. Budesonide 
 Budesonide is a non- halogenated corticosteroid. It used in topical 
preparations. It is a good marker of wide range of cortisone allergy. 
  
Coopman classification of corticosteroids based on frequency of cross 
reactivity  
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Class A 
Hydrocortisone type 
Ex. Hydrocortisone with C17 and/or C21 –acetate,tixocortol pivalate, 
prednisone+/-acetate, methyl  prednisolone+/- acetate 
Class B  
Triamcinolone type 
Ex.Triamcinolone acetonide or alcohol, budesonide, desonide, 
halcinonide, amcinonide 
Class C 
Betamethasone type (not valerate) 
Ex.betamethasone and disodium phosphate, dexamethasone and 
disodium phosphate, desoximetasone 
Class D1 
Less labile 
Ex.Clobetasol propionate and butyrate, betamethasone valerate  and 
dipropionate, mometasone furoate, beclomethasone dipropionate 
Class D2 
More labile 
Hydrocortisone -17-butyrate and 17-aceponate and 17-buteprate, 
Prednicarbate. 
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Rim reaction or edge effect  
Erythema occurs only around the circumference of  the chamber, 
represents true sensitization. This phenomenon is seen with corticosteroids. 
 
Lauerma reported that classes A,B and D cross reacted most frequently 
and he proposed tixocortol pivalate and hydrocortisone-17-butyrate as a good 
screening combination.  Class B rarely cross reacted with class C.  Class C is 
the least common corticosteroid allergen in Finland. 
 
Contact allergy to budesonide has been reported from nasal sprays and 
oral inhalers. A study of 30 patients on inhaled corticosteroids found that 2 
patients were sensitized to budesonide
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Recommended concentration for patch testing with budesonide is 0.1% 
in petrolatum. budesonide sensitized patient should avoid triamcinolone, 
amcinonide, fluocinolone acetonide, halcinonide, flucinonide,desonide and any 
others that end with the letters “….ide”. 
 
Budesonide Indian brand name 
Budesal respules,budecort respules,budenase AQ spray,budecort 
neohaler,foracort rotacap,rhinocort  rota cap,combihale –FB inhaler 
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18. Triethanolamine   
 
Triethanolamine is also known as trolamine or TEA. It is a mixture of 
three alkanolamines. It is used frequently as an excipient in body lotions, 
shaving creams, soaps, shampoos, bath powders, and pharmaceutical 
preparations. 
 
Excipient : An  inert substance that gives a topical preparation proper 
consistency by its action as a dispersant or detergent.  Excipient should have no 
pharmacological action by themselves, but may cause allergic reaction in 
sensitive individual.  
   
Castelain reported allergic contact dermatitis due to sensitization to 
TEA. Triethanolamine can cross react with phenergan.
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  It is a more common 
sensitizer in industrial products than in cosmetic products. In one patient, a 
fluorescent marking pen used in patch testing caused allergy from 
triethanolamine 
Triethanolamine containing products 
Sungrace and suncote gel - sunscreen 
Acnemoist - moisturiser 
Dermadew lotion – moisturiser 
 
20. Framycetin Sulphate 
Framycetin is a broad spectrum aminoglycoside antibiotic. It is usually 
bactericidal in action. Although the exact mechanism of action has not been 
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fully elucidated, the drug appears to inhibit protein synthesis in susceptible 
bacteria by binding to ribosomal subunit (30s protein). 
 
Framycetin is active against many aerobic gram-negative bacteria and 
some aerobic gram-positive bacteria. It is inactive against fungi, viruses and 
most anaerobic bacteria. 
 
It is a component of neomycin that is produced by streptomyces fradiae. 
On hydrolysis framycetin yields neamine and neobiosamine B . 
Indications  
 Pyoderma,folliculitis,paronychia,sycosis barbae,impetigo 
 Also useful in controlling secondary bacterial infection in skin 
carcinoma,eczema,contact dermatitis,seborrhea,acne,psoriasis,varicose 
ulcer and neurodermatitis 
 Treatment of blepharitis,conjunctivitis,styes,corneal abrasions,burns. 
 
Framycetin sulphate Indian brand names 
 Proctosedyl ointment.2.sofradex cream 3.sofradex-F cream4.sofracort 
drop5.soframycin cream 5.sofra-Tulle 6.famitulle antibiotic dressing. 
 
Cross reaction: 
  Neomycin, Parommycin, Kanamycin. 
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21. Sorbitan Sesquioleate 
 
Sorbitan sesquioleate is derived from monoesters and diesters of oleic acid and 
hexitol anhydrides of sorbitol. It is a common non-ionic emulsifier.  
  
 Case reports have described contact allergy to both sorbitan sesquioleate 
and Sorbitan monoleate. Contact dermatitis from Sorbitan sesquioleate has 
been reported to be caused by wound dressings and a topical corticosteroid 
preparation (patch-test concentrations of 20% and 10% in petrolatum, 
respectively).
115
 
 
 A  case series of children also noted contact allergy to Sorbitan 
sesquioleate (20% in petrolatum) in certain paediatric products as well as in 
topical corticosteroid preparations.
116
 
 
 Case reports have reported that patients with leg ulcers had positive 
patch-test reactions to Sorbitan sesquioleate 2% in petrolatum, Sorbitan 
monoleate 2% in petrolatum, and Sorbitan monoleate 20% in petrolatum.
117
 
  
 A larger series of 23 leg ulcer patients found that 17% were allergic to 
Sorbitan monoleate (10% petrolatum) and that 13% were allergic to Sorbitan 
sesquioleate (20% petrolatum).
118 
Indian brands with sorbitan sesquioleate 
Pramosone cream and ointment  - topical steroid 
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22. Tixocortol-21-pivalate(pivalone) 
 
 Tixocortol-21-pivalate is a class A (hydrocortisone type) corticosteroid. 
It is most sensitive and specific marker for hydrocortisone contact allergy. It is 
mainly used for contact dermatitis screening rather than treatment.   
 
Patients with tixocortol-21-pivalate allergy should avoid hydrocortisone, 
prednisone, prednisolone and methlprednisolone. Dexamethasone and 
betamethasone are safer internal corticosteroids in these patients. 
 
23. Sorbitan Monoleate 
 Sorbitan monoleate is a monoester of oleic acid and hexitol anhydrides 
derived from sorbitol. It is used as a emulsifier in cosmetic and pharmaceutical 
ointments and creams. It can cross react with sorbitan sesquioleate. 
 
24. Phenyl mercuric acetate 
Chemical formula: C8H8HgO2 
 
 Phenyl mercuric acetate is an organo mercurial derivative. It is used as a 
bacteriostatic agent. It is also used as a preservative in antibiotic eye drops and 
cosmetics. Systemic administration of medication containing mercury can 
cause allergic contact dermatitis in sensitized persons. It is used in 
contraceptives, antifungal agents, shoe linings, shampoos and emulsion paints. 
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Cross reaction 
Organic mercuric compounds: phenyl mercuric borate and phenyl 
mercuric nitrate. 
Inorganic salts: ammoniated mercury and bichloride of mercury. 
 
Indian brands with phenyl mercuric acetate 
Betal –N drops – betamethasone +neomycin 
betnor drop – betamethasone. 
  
25.Chloroacetamide 
Chemical formula: C2H4ClNO 
Choloroacetamide is a water soluble preservative useful against yeast 
and fungi. It is used in cosmetic products, paints, shoes, adhesives and cutting 
oil. It is used as an intermediate in the production of herbicides and 
insecticides. Chloroacetamide is banned in France because chloroacetamide is a 
category 3 mutagenic or reproductive toxin.  
 
Axillary dermatitis from a deodorant has been reported from Australia. 
Currently, patch testing is performed with chloroacetamide 0.2 % in 
petrolatum. one study from Swiss out of 2,295 patients only 1.5% of the 
patients showed chloracetamide sensitization.
119 
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26.Diazolindinyl Urea 
Chemical formula:C8H14N4O7 
Diazolindinyl urea is a formaldehyde releasing preservative. It is 
produced by the chemical reaction of allantoin and formaldehyde in the 
presence of sodium hydroxide solution and heat. 
 
 It has antibacterial and antifungal action. It was introduced in 1982.  It 
is used in cosmetic creams, lotions, shampoos and hair gels It is a stronger 
sensitizer than imidazolidinyl urea.  
 
It is also known as Germall II. As per data collected from 2002-2004 
NACDG, prevalence of contact allergy to diazolindinyl urea is 3.5%.
120   
Cross-
sensitivity between Diazolindinyl Urea and Imidazolidinyl Urea is common but 
does not always occur. 
Five commonly used formaldehyde-releasing preservatives  
1. Bronopol 
2. Diazolidinyl urea 
3. DMDM hydantoin 
4. Imidazolidinyl urea 
5. Quaternium- 15 
 
Diazolidinyl urea containing preparations 
 Acnemoist - moisturizer 
 Papulex - moisturizer 
 Suncote gel -sunscreen 
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27. Imidazolidinyl Urea 
 
Imidazolidinyl urea is a formaldehyde releasing preservative. It is also 
known as Germall 115. It is one of the most commonly used cosmetic 
preservative after paraben. It is non-toxic, non-irritating, so it is compatible 
with almost all cosmetic ingredients.  It is used as a preservative in lotions, 
creams, hair conditioners, shampoos, deodorants and topical drugs. 
 
It is highly water soluble, colourless, odourless, tasteless and is not pH 
dependent. Imidazolidinyl urea is more active against bacteria than against 
yeast and moulds. It is active against both gram-positive and gram negative-
organisms. In one case report, six out of fifteen imidazolidinyl urea sensitive 
patients reacted to formaldehyde.
121
  Theoretically, imidazolidinyl urea releases 
about one-eighth as much formaldehyde as Quaternium-15.  
 
It acts synergistically with other preservatives, particularly with the 
parabens, which results in wide range of antimicrobial coverage. In one study, 
out of 30 formaldehyde –allergic patient only one patient had reacted to 
imidazolidinyl  urea, where as 9 reacted to quaternium -15.   
 
Indian products with imidazolidinyl urea  
Flutivate cream – fluticasone propionate 
Tenovate GN cream – clobetasol propionate+neomycin 
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28. Wood Tar Mix 
 
Wood tar mix include pine tar, beech tar, juniper tar (oil of Cades) and 
birch tar(oleum rusci). They are used in shampoos, deodorants, cough syrups, 
counter irritant veterinary liniments, tooth powders, disinfectants and 
insecticides. 
 
Allergic reactions were found in only 1.8% of patients. Positive reaction 
to coal tar and wood tar are more frequent among balsum of peru sensitive 
patient. . Coal tars are phototoxic but wood tars are not phototoxic. 
 
Tar  
 It is a dark-brown or black, viscid liquid obtained from various species 
of pine or from bituminous coal. 
 
Juniper Tar (oil of cade) 
It is a volatile oil obtained from wood of juniperus oxycedrus. Mathias 
and colleagues
122
 reported that juniper tar is an irritant and it should be tested at 
half its commercial strength or at a low concentration. 
 
Pine Oil 
It is a mixture of terpene alcohols, hydrocarbons, and ethers. It can 
produce serious toxic effects if ingested or aspirated. 
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Birch Tar Oil (Oleum  Rusci) 
Rothenborg and Hjorth
123
 reported that positive patch test reactions to a 
mixture of wood tars consisting of pine, juniper, beech and birch produce false-
positive reactions. When a wood tar mix is positive, each tar should be tested 
individually. 
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TABLE -7 
LEG ULCER SERIES ALLERGENS 
 
S.NO ANTIGENS Group 
1. Control - 
2. Amerchol L 101 Emollient 
Emulsifier  
3. Fusidic acid sodium salt Antimicrobial agent 
4. Chlorhexidine digluconate Antimicrobial agent 
5. Benzalkonium chloride Disinfectant  
6. Nitrofurazone Antimicrobial agent 
7. Bacitracin  Antimicrobial agent 
8. Cetyl stearyl alcohol 
(Lanettee) 
Emollient  
Emulsifier 
Preservative  
9. 2,6 Ditert-butyl-4-cresol(BHT) Antioxidant 
Antimicrobial agent 
10. Chloramphenicol Antimicrobial agent 
11. Benzoyl peroxide Topical acne 
 Preparations 
Treatment of leg ulcer. 
12. Propylene glycol Vehicle for topical preparations 
Antimicrobial 
Antifungal  
Preservative  
13. Propolis Cosmetic related to balsum of peru 
Treatment of leg ulcer 
14. Thimerosal(Meethiolate) Preservative  
Antiseptic 
Excipient  
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 15. Sorbic acid Preservative  
Antifungal  
16. Eosin Topical antibacterial preparation 
17 4-Chloro-3-cresol(PCMC) 
 
 
Preservative 
Antiseptic 
Anti bacterial 
Disinfectant 
Antifungal 
Excipient  
18 Budesonide Corticosteroid 
19 Triethanolamine Excipient 
20 Framycetin sulphate Antibacterial  
21 Sorbitan sesquioleate Excipient 
Emulsifier  
22 Tixocortol-21-pivalate Corticosteroid  
23 Sorbitan monoleate(span 80) Emulsifier  
24 Phenyl mercuric acetate Preservative 
Bacteriostatic agent 
25 Chloroacetamide Preservative 
Antifungal  
26 Diazolindinyl urea(Germall ii) Preservative  
Antifungal  
Antibacterial  
27 Imidazolidinyl urea(Germall 
115) 
Preservative  
Antifungal  
Antibacterial 
28 Wood tar mix Fragrance, plant extract. 
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94 
 
MATERIALS AND METHODS 
Study design 
         This study was done as a hospital based descriptive, observer blinded 
study 
 
Study  Population 
      Chronic leg ulcer patients aged 18 years and older, male or female, 
attending the Dermatology OP were included in  the study. A total of 50 
patients with chronic leg  ulcers with or without surrounding dermatitis due to 
various causes is selected. 
 
Study Period 
This study was done during a period of 18 months after obtaining 
clearance from the ethical committee. Written informed consent was taken 
from all patients involved in our study. 
 
Inclusion Criteria 
         -50 chronic leg ulcer patients with or without surrounding dermatitis were 
included in this study.  
Exclusion Criteria 
        1. Patients are having acute skin eruptions on the back.      
        2. Patients are taking oral corticosteroids more than 20mg per day. 
        3. Patients on any other immunosuppressant‟s 
        4. Pregnant and lactating mother 
        5. Age <18 years 
95 
 
Methods  
 50 patients with chronic leg ulcer were recruited and informed consent 
was obtained. 
 Detailed history and clinical examination was performed (enclosed in 
proforma) 
 The leg ulcer series is obtained from chemo technique which consists of 
28 allergens. These allergens were applied on finn chambers and were 
strapped to the back of the patients with tapes. 
 The patches must stay in place undisturbed for at least  48 hours. 
vigorous exercise, stretching, shower and sun light exposure should be 
avoided. 
 After 48 hours, the finn chambers were removed and the squares 
representing each chamber were marked using a marker pen. 
 Readings were taken after half an hour and again second reading were 
taken at 72 hours.   
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INTERPRETATION OF THE RESULTS 
The patch test results were scored using the International Contact 
Dermatitis Research Group grading 
 
Table - 8 
ICDRG CRITERIA 
Score  Reaction 
− (0) Negative 
? + Doubtful reaction; faint erythema only 
+ 
 
Weak positive reaction; palpable erythema, infiltration,   
possibly papules 
++ Strong positive reaction; erythema, 
infiltration,papules,vesicles 
+++ 
 
Extreme positive reaction; intense erythema and infiltration 
and coalescing vesicles 
IR Irritant reaction of different types 
NT Not tested 
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TABLE - 9  
LEG ULCER SERIES 
S.No. ANTIGEN % Vehicle 
01 Control   
02 Amerchol L 101 50 Pet 
03 Fusidic acid sodium salt 2 Pet 
04 Chlorthexidine digluconate 0.5 Aq 
05 Benzalkonium chloride  0.1 Aq 
06 Nitrofurazone 1 Pet 
07 Bacitracin 5 Pet 
08 Cetyl Stearyl alcohol (Lanettee O) 20 Pet 
09 2,6 Ditert-buty1-4-cresol (BHT) 2 Pet 
10 Chloramphenicol 5 Pet 
11 Benzoylperoxide 1 Pet 
12 Propylene glycol 5 Pet 
13 Propolis 10 Pet 
14 Thimerosal (Merthiolate) 0.1 Pet 
15 Sorbic acid 2 Pet 
16 Eosin 5 Pet 
17 4-Chloro-3cresol (PCMC) 1 Pet 
18 Budesonide* 0.01 Pet 
19 Triethanolamine 2 Pet 
20 Framycetin sulphate 20 Pet 
21 Sorbitan Sesquioleate 20 Pet 
22 Tixocortol-21-pivalate 0.1 Pet 
23 Sorbitan Monoleate (Span 80) 5 Pet 
24 Phenyl Mercuric acetate 0.01 Aq 
25 Chloroacetamide 0.2 Pet 
26 Diazolindinyl urea (Germall II) 2 Pet 
27 Imidazolidinyl urea (Germall 115) 2 Pet 
28 Wood tar mix (Pine, beech, Juniper, Birch) 12 Pet 
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Table - 10 
AGE AND SEX DISTRIBUTION 
 
Age in years 
Sex 
Total Percentage 
         Male    Female 
10 - 20 0 0 0 0 
21-30 5 0 5 10 
31-40 5 3 8 16 
41-50 4 1 5 10 
51-60 7 1 8 16 
61-70 12 4 16 32 
71-80 4 0 4 8 
81-90 4 0 4 8 
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Fig .4 
 
 
Fig 5  
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TABLE - 11 
DURATION OF ULCER 
Duration of ulcer 
in months 
Number of 
patients 
% 
Number  of patients 
with positive patch 
test 
% 
  0-3 17 34 14 82.4 
3-6 12 24 7 58.3 
6-12 7 14 5 71.4 
12-60 8 16 5 62.5 
>60 6 12 5 83.3 
   
 
 
Fig .6
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Table - 12 
OCCUPATION 
S.No Occupation Number  Percentage  
1. Business  4 8 
2. Farmers  6 12 
3. Housewives  9 18 
4. Retired 6 12 
5. Un employed 9 18 
6. Nurse 1 2 
7. Teacher 2 4 
8. Labour 9 18 
9. Miscellaneous 4 8 
 
 
 
Table – 13 
 
HISTORY 
 
S.NO History 
Number of patients 
– yes 
Number of patients-
No 
 1. Varicose vein 24 26 
2. Claudication pain 4 46 
3. Rest pain 6 44 
4. Trauma 11 39 
5. Anaesthesia 5 45 
6. Diabetes 15 35 
7. Hypertension  10 40 
 
103 
 
Table - 14 
PREVIOUS TREATMENTS (TOPICAL) 
S.No Topical preparations 
Number of patients –
Applied 
Number of patients-
Not Applied 
1. Emollient 26 24 
2. Antibiotics 30 20 
3. Steroid 23 27 
4. Antiseptic 7 43 
5. Combination 13 37 
  
 
 
 
 
 
 
 
 Table - 15   
PREVIOUS TREATMENTS (SYSTEMIC) 
S.NO Systemic treatment 
Number of patients-
taken 
Number of patients- 
not taken 
 
1. 
 
Antihistamines 13 37 
2. 
 
Antibiotics 30 20 
3. 
 
Steroids 6 44 
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Table - 16  
RESPONSES TO TREATMENT 
 
 
 
TABLE - 17 
EXAMINATION FINDINGS 
 
S NO Examination findings Present Not present 
1. Varicose vein 22 28 
2. Deformities of limb   5 45 
3. Edema of leg 36 14 
4. Peripheral pulsation 46 4 
 
 
S.NO Response to treatment Number of patients 
1. Improved  21 
2. Not improved 24 
3. Worked 5 
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EXAMINATION FINDINGS 
 
TABLE -18 
EXAMINATION OF (ULCER) SURROUDING SKIN 
S.NO Surrounding  skin Present % Not present % 
1. Pigmentation  38 76 12 24 
2. Indurations  25 50 25 50 
3. Dermatitis 40 80 10 20 
 
 
 
Fig 7 
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Fig.8 
 
Table - 19 
ULCER SITE 
S.NO Site No of patients % 
1. Lateral aspect of  leg 2 4 
2. Medial aspect of leg 2 4 
3. Lateral malleolus 6 12 
4. Medial malleolus 16 32 
5. Plantar aspect 2 4 
6. Shin 2 4 
7. Dorsal aspect of foot 20 40 
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Table - 20 
CAUSES OF LEG ULCERS 
S.No  Causes for leg ulcer No of patients Percentage 
1. Venous ulcer  28 56 
2. Mixed ulcer 5 10 
3. Pyoderma gangrenosum 5 10 
4. Vasculitic ulcer 3 6 
5. Trophic ulcer 3 6 
6. Factitious ulcer 1 2 
7. Others 5  10 
 
 
Table - 21 
FREQUENCY OF ALLERGENS POSITIVITY 
S.NO 
Frequency of number of 
allergens  positive 
No of patients % 
 1. One allergen positive 7 19.4 
2. Two allergen positive 10 27.8 
3. Three allergen positive 10 27.8 
4. Four allergen positive 3 8.3 
5. Five allergen positive 3 8.3 
6. Six allergen positive 2 5.6 
7. Eleven allergen positive 1 2.8 
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Fig.9 
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Table - 22 
LEG ULCER SERIES ALLERGENS POSITIVITY 
S.NO ANTIGENS 
NO OF 
PATIENTS 
(POSITIVE) 
PERCENTAGE 
 1. Control 0 0 
2. Amerchol L 101 3 8.3% 
3. Fusidic acid sodium salt 2 5.5% 
4. Chlorhexidine digluconate 4 11.11% 
5. Benzalkonium chloride 9 25% 
6. Nitrofurazone 1 2.78% 
7. Bacitracin 4 11.11% 
8. Cetyl stearyl alcohol(Lanettee) 3 8.3% 
9. 2,6 Ditert-butyl-4-cresol(BHT) 1 2.78% 
10. Chloramphenicol 1 2.78% 
11. Benzoyl peroxide 1 2.78% 
12. Propylene glycol 5 13.89% 
13. Propolis 4 11.11% 
14. Thimerosal(Meethiolate) 9 25% 
15. Sorbic acid 2 5.5% 
16. Eosin 4 11.11% 
17 4-Chloro-3-cresol(PCMC) 11 30.55% 
18 Budesonide 1 2.78% 
19 Triethanolamine 2 5.5% 
20 Framycetin sulphate 10 27.78% 
21 Sorbitan sesquioleate 2 5.5% 
22 Tixocortol-21-pivalate 0 0 
23 Sorbitan monoleate(span 80) 5 13.89% 
24 Phenyl mercuric acetate 4 11.11% 
25 Chloroacetamide 2 5.5% 
26 Diazolindinyl urea(Germall ii) 2 5.5% 
27 Imidazolidinyl urea(Germall 115) 4 11.11% 
28 Wood tar mix 11 30.55% 
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Fig .10 
 
 
 
Fig 11 
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Fig 12 
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DISCUSSION 
  In our study out of 50 patients, 41 patients were males and 9 patients 
were females. The duration of leg ulcers when patch tests were carried out was 
0-3 months in 17 patients, 3-6 months in 12 patients,6-12 months in 7 
patients,12-60months in 8 patients and >60months in 12 patients. 
 
In our study ulcer duration was not associated with sensitization rate, but 
a number of European studies showed a significant correlation between ulcer 
duration and contact sensitization.
5 
 
From this study, we conclude that contact sensitization and 
polysensitization are very common in chronic leg ulcer patients. In our study 
36 patients (72%) showed positive patch test reactions. Over all 14% had at 
least one positive reaction, 58% demonstrated 2 or more positive reactions in 
our study.  
 
 A North American study
7
 reported prevalence of sensitization was 63% 
which was low compared with our study but another study
6
 showed 80% 
positivity which was high compared with our study.    
 
Out of 36 patients, 11 patients (30.5%) showed positive reaction to 4-
chloro3-cresol and wood tar mix. 4-chloro-3-cresol and wood tar mix was the 
most common sensitizer in our study whereas western study showed only 2% 
chlorocresol positivity.
2
  Although 4-chloro-3-cresol is an infrequent allergen 
in other countries, in India 4-chloro3-cresol positivity is high. 
114 
 
 Since it is present in most of the corticosteroids creams, patients who 
have tested positive for chlorocresol should avoid steroid cream containing 
chlorocresol.  
 
Various studies have reported chlorocresol sensitivity. Oleffe and 
colleagues reported allergic reaction to chlorocresol in corticosteroid creams.
124
 
Park in New Zealand reported a case who had allergy to chlorocresol in 
betamethasone cream.
125 
 
Of 1000 patients who had contact dermatitis analysed by Burry and 
colleagues, only 11 patients reacted to chlorocresol.
126
 Dermatitis from 
chlorocresol in betamethasone creams was reported in 13 patients. (Burry and 
colleagues )
126 
 
 Sensitization rates to wood tar mix as per various studies are 2.8% , 
3.4%,4.5%,15%,20% and 21%,
7,127,128,129,130
 but our study sensitization rate to 
wood tar mix (30.5%) was high comparatively. 
 
Wood tar mix is not used in leg ulcer treatment, but it is found in many 
cosmetics and personal care products. It can also cross react with balsum of 
peru and fragrance mix. So high rate of contact allergy to wood tar mix could 
be due to cross reaction with this allergens.
7 
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The second most common sensitizer in our study was framycetin 
sulphate. In contrast to other studies (39%, 7%)
2,7 
 our study 10(27.8%) patients 
showed positive reaction to framycetin sulphate. 
 
The world literature series showing sensitization to neomycin and 
framycetin was around 12 to 16% from1975 to 2003.
131 
 
In India most of the topical antimicrobial creams contain framycetin and 
neomycin combination. It is usually combined with antifungals and steroids. So 
high incidence of framycetin positivity could be due to cross reaction with 
neomycin.     
 
Cross reaction can occur between neomycin and framycetin because 
both groups contain neosamine sugar.
130 
 
The third most common sensitizers were bezalkonium chloride and 
thimerosal. Bezalkonium chloride is a disinfectant and thiomerosal is antiseptic 
and preservative.  
 
 In our study 9 patients (25%) showed positive reaction to benzalkonium 
chloride and thiomerosal whereas in western studies benzalkonium chloride 
contact allergy rates were 8% , 13%
7,130
 and for thimerosal  4%,4%
7,130
 which 
was low compared with our study. 
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Sorbitan monoleate and propylene glycol proved to be next most 
frequent sensitizers. Sorbitan monoleate is an emulsifier and propylene glycol 
is used as vehicle in various creams.  
 
In India most of the emollients and steroid creams contain propylene 
glycol which explains why contact allergy to propylene glycol was high in our 
study.   5 patients (13.9%) showed positive reaction to these two agents in our 
study. Similar frequency 14% was reported for propylene glycol from North 
America
7
 but sorbitan monoleate sensitization rate was very low (0.9%) in 
another study
132 
 
In our study, 4 patients (11%) showed positive reactions to 
chlorhexidine digluconate, bacitracin, propolis, eosin, phenyl mercuric acetate 
and imidazolidinyl urea.   
 
Chlorhexidine which is commonly used antiseptic agent in India was 
positive in 11% of patients whereas in one meta analysis chlorhexidine 
positivity was 4%.
133
  
 
Other studies showed sensitization rate to bacitracin, ranging from 
6.7%,8%,24% whereas our study showed 11% positive patch test reaction.
7,130
 
Bacitracin and neomycin combinations are most commonly used „over the 
counter product‟ in India leading to increased chance of contact allergy to 
bacitracin. 
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 Our study showed high rate of contact allergy to propolis(11%) 
compared to a study from Canada(4%)
130
. This could be due to cross reaction 
of propolis  with balsum of peru which is present in various cosmetics.  
Propolis is used for leg ulcer treatment in western countries but in India it is 
rarely used for this purpose.  
 
Imidazolidinyl urea which is used as a preservative in corticosteroid 
creams was positive in 11.11% in this study, whereas in a study from North 
America imidazolidinyl urea positivity was 7%.
7 
 
Topical bacteriostatic preparation contains eosin mainly in the western 
countries. However in India it is not available. Phenyl mercuric acetate is used 
as a preservative in various steroid and antibacterial combination creams. 
 
Amerchol L 101 and cetyl stearyl alcohol were positive in 3(8.3%) 
patients in our study whereas one study  showed 7% Amerchol L 101 
positivity. 
130
Amerchol positivity in our study could be due to cross reaction 
with lanolin which is present in most of the emollients and tulle type of 
dressing. 
 
In contrast to other studies (6%,2.3%),
130,134   
our study sensitization 
rates to cetyl stearyl alcohol was high(8.3%). Cetyl stearyl alcohol is used as a 
preservative in almost all moisturisers and steroid creams. 
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In our study, only 2(5.5%) patients showed positive reaction to fusidic 
acid sodium, sorbic acid, triethanolamine, sorbitan sesquioleate, 
chloroacetamide  and diazolindinyl urea . 
  
Our study positivity rate to fusidic acid sodium salt was low (5.5%) 
compared with a study from Scotland  (9%).
2
   Fusidic acid sodium salt is not a 
frequent sensitizer. 
 
 Diazolindinyl urea which is used as a preservative in emollients, 
personal care products and sunscreen was positive  in 5.5% in our study  
whereas in  a western Study, diazolidinyl urea positivity was 4%
7 
 
Triethanolamine which is used as an excipient in various creams and 
ointments was positive in 5.5% in our study whereas in a study from Serbia, 
triethanolamine positivity was 2.7%
136 
 
 
Chloroacetamide is present in various cosmetics. Compared   with 
Swiss study(1.5%) 
119
, chloroacetamide positivity(5.5%)  is high in our study.  
 
Rare allergens in our study were Nitrofurazone, 2,6 Ditert-butyl-4-
cresol,chloramphenicol,benzoyl peroxide and budesonide which showed 
positive reactions in only one(2.8%) patient. None of the patient showed 
positive reaction to tixocortol-21-pivalate. 
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Although nitrofurazone is a known sensitizer in leg ulcer patient, in our 
study sensitization rate was low, because in India it is not a commonly used 
topical antibiotic. 
 
Other studies showed prevalence of sensitization to budesonide, ranging 
from 2.3%
134
, 2.9%
6
, 3%
2
 to 20%
135
 but our study showed 2.8%. Tixocortol 21 
pivalate and budesonide is most sensitive indicator of steroid allergy. 
 
In our study only 2.8% of patients were positive for chloramphenicol. In 
India chloramphenicol is available mainly as eye drops and ointments. So rate 
of contact allergy was low in our study. 
 
In our study benzoyl peroxide positivity was 2.8% whereas western 
literature it was 7%
130
. Unlike the western countries benzoyl peroxide is rarely 
used for leg ulcer treatment in India. So sensitization to bezoyl peroxide was 
low in ours. 
 
 In contrast to several studies (2%
135
,2.3%
134
) in our study none of the 
patient showed positive patch test reaction to tixocortol 21 pivalate. 
 
Various differences exist in the percentage of allergen positivity in our 
study as compared to western literature. In our study one patient had multiple 
(11) positive reaction which was considered as angry back syndrome.  
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Patients own products  were patch tested in 5  patients ,One patient was 
patch tested with Fenlong ointment (Diclofenac+capsaicin), but patch test 
reading was negative. 
 
 Another  patient  was tested with mehaheal(colloidal silver) and centis 
cream (ayurvedic cream which contain Centella Asiatica extract: 1.5%).In that 
patient mehaheal patch test showed negative result but centis cream was 
positive.  In our study, 3 patients were patch tested with T.Bact (Mupirocin) 
which showed negative results  
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CONCLUSION 
 
 Our study showed a high rate of contact sensitization in leg ulcer 
patients. Most common allergens in our study were 4-chloro 3-creso 
l(preservative in steroid creams),wood tar mix (cosmetic related to balsum of 
peru), framycetin sulphate (antimicrobial) followed by benzalkonium chloride 
(disinfectant) and thiomerosal (preservative ,antiseptic). Percentage of positive 
allergens reflects the local wound care practices for leg ulcer, particularly the 
use of topical steroids and antimicrobial. By avoiding that particular allergen 
we can prevent secondary sensitization which will promote the wound healing. 
So we recommend patch testing for leg ulcer patients with or without 
dermatitis, so as to prevent delayed wound healing.     
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Picture 1 : Patient with leg ulcer 
 
 
 
Picture 2: Leg ulcer with surrounding dermatitis 
  
Picture 3 : Patch test kit – leg ulcer series antigens 
 
 
Picture 4: Strips applied on patient’s back 
 
 Picture 5: Leg ulcer with surrounding dermatitis 
 
 
Picture 6: Same patient with wood tar mix positivity 
 
 Picture 7: Patient with multiple positivities 
 
   
Picture 8:  Grade 2+   positive patch test reactions 
 PATCH TESTING CONSENT FORM 
 
 I, the undersigned, do herby consent for undergoing 
PATCH TESTING. 
 
I confirm that the details of the procedure, its side effects 
and benefits have been explained to me in a language that I 
understand. I have been given the opportunity to clarify any 
concerns that I have and sign this consent form freely and 
voluntarily. 
 
I give my full consent for all of the aforementioned. 
 
Name       :         ____________________ 
Signature :         ____________________  
 Xg;gjy; gotk; 
 
 ………………………… Mfpa ehd;/ ngl;R ghpl;ir 
bra;J bfhs;s rk;kjpf;fpnwd;.  ,e;j ghpl;iriag; gw;wpa 
bray;Kiw kw;Wk; gf;f tpist[fs; midj;Jk; vdf;F ehd; 
g[hpe;J bfhs;sf;Toa bkhHpapy; kUj;Jth;fshy; 
tpsf;fg;gl;lJ.  ,e;j ghpl;iria bra;J bfhs;s ehd; KG 
rk;kjk; mspf;fpnwd;. 
 
ifbahg;gk; : 
bgah;  : 
njjp   : 
 
 
 
PATCH TEST – LEG ULCER PROFORMA 
       Date : 
Personal Details 
Name :   Occupation :    Hosp. No. 
Age    :   Address & Phone No.: 
Sex    :  
History 
1.  Duration of Ulcer:
    
2.  Varicose Vein  : Yes  / No 
    Claudication  :  Yes / No 
3.  Pain  : 
    Rest Pain :  Yes / No 
 
4.  Trauma  : Yes / No 
5.  Anesthesia : Yes / No 
6.  Diabetes  : Yes / No 
7.  Hypertension : Yes / No 
8.  Previous Treatment: 
 Topical    :    Emollient    :    
   Antibiotics  : 
        Steroid    : 
   Antiseptic  : 
   Combination   : 
   Duration : 
 Systemic :   Antihistamine       Antibiotic               Steroid   
 Surgery   :   Yes / No 
   Details: 
 Response to treatment  : Improved  / Not Improved / worked 
 
9.  Use of Stockings / Crepe Bandage: Yes / No 
0-3 month 3-6 month 6-1 year 1-5 year >5 year 
     
 Examination 
1.  Varicose vein   : Present  / Not Present 
2.  Deformities of limb  : Present  / Not Present 
3.  Ulcer :  size  : 
4.  Site    : 
5.  Bilateral / Unilateral : 
6.  Number   : 
7.  Edges   : Regular / Irregular 
     Punched out / Sloping 
8.  Surrounding Skin 
 Pigmentation  : Present  / Not Present 
 Induration  : Present  / Not Present 
 Dermatitis  : Present  / Not Present 
 
9.  Edema of the Leg  : 
 
10. Maggots   : 
 
11.  Foul Smelling  : 
 
12. Peripheral Pulsation : 
 
13. Diagnosis   : 
 
 
 Investigations 
1.        CBC   
2.   S. Protein 
3.   RBS / FBS / PPBS / HbA1 C 
4.   Pus Culture / Sensitivity 
           Arterial 
5.   Doppler 
           Venous 
 
6.   Lupus Anticoagulant 
 
7.   Homocysteine 
 
8.   ANCA 
  
9.   AFB 
 
10.  X-ray 
 
11.   Biopsy 
 
 
Results  of  ISS  patch  test  :      48 hrs        72  hrs  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
LEG ULCER SERIES 
S.No. ANTIGEN % DAY 
DAY 
3 4 5 
01 Control      
02 Amerchol L 101 50     
03 Fusidic acid sodium salt 2     
04 Chlorthexidine digluconate 0.5     
05 Benzalkonium chloride 0.1     
06 Nitrofurazone 1     
07 Bacitracin 5     
08 Cetyl Steary alchohol (Lanettee O) 20     
09 2,6 Ditert-buty1-4-cresol (BHT) 2     
10 Chloramphenicol 5     
11 Benzoylperoxide 1     
12 Propylene glycol 5     
13 Propolis 10     
14 Thimerosal (Merthiolate) 0.1     
15 Sorbic acid 2     
16 Eosin 5     
17 4-Chloro-3cresol (PCMC) 1     
18 Budesonide* 0.01     
19 Triethanolamine 2     
20 Framycetin sulfate 20     
21 Sorbitan Sesquioleate 20     
22 Tixocortol-21-pivalate 0.1     
23 Sorbitan Monoleate (Span 80) 5     
24 Pheny Mercuric acctate 0.01     
25 Chloroacetamide 0.2     
26 Diazolindinyl urea (Germall II) 2     
27 Imidazolidinyl urea (Germall 115) 2     
28 Wood tar mix (Pine, beech, Juniper, Birch) 12     
  
COMPLETE SERIES 
 
     
 
*According to ESCD and  EECDRG studies, test reading on recommended. 
 
 
 
 
 
 
 
 
 
 
 ABBREVIATIONS 
 
DVT    Deep Vein Thrombosis 
PG   Pyoderma Gangrenosum  
ABPI  Ankle brachial pressure index 
PDL  Pulsed dye laser 
TRUE test Thin layer rapid use epicutaneous test. 
CVI Chronic venous in sufficiency 
ACD Allergic Contact Dermatitis 
BZK Benzalkonium chloride 
ROAT  Repeat Open Application test  
BHT Butylated hydroxyl toluene 
PG  Propylene Glycol 
TEA   Triethanolamine 
 
MASTER CHART CODES 
 0 No,    Negative 
1 Yes, Positive 
1-28 Leg ulcer series allergens 
